EP1009751A2 - Improvements in or relating to stability of plant starches - Google Patents
Improvements in or relating to stability of plant starchesInfo
- Publication number
- EP1009751A2 EP1009751A2 EP98941593A EP98941593A EP1009751A2 EP 1009751 A2 EP1009751 A2 EP 1009751A2 EP 98941593 A EP98941593 A EP 98941593A EP 98941593 A EP98941593 A EP 98941593A EP 1009751 A2 EP1009751 A2 EP 1009751A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- plant
- starch
- sequence
- nucleic acid
- isoamylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920002472 Starch Polymers 0.000 title claims description 81
- 235000019698 starch Nutrition 0.000 title claims description 81
- 230000006872 improvement Effects 0.000 title description 2
- 108010028688 Isoamylase Proteins 0.000 claims abstract description 53
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 51
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 45
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 33
- 241000196324 Embryophyta Species 0.000 claims description 110
- 239000008107 starch Substances 0.000 claims description 73
- 108090000623 proteins and genes Proteins 0.000 claims description 46
- 102000004190 Enzymes Human genes 0.000 claims description 40
- 108090000790 Enzymes Proteins 0.000 claims description 40
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 39
- 108090000637 alpha-Amylases Proteins 0.000 claims description 36
- 230000000692 anti-sense effect Effects 0.000 claims description 24
- 238000004458 analytical method Methods 0.000 claims description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 240000008042 Zea mays Species 0.000 claims description 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 10
- 235000009973 maize Nutrition 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 229920000856 Amylose Polymers 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 235000010582 Pisum sativum Nutrition 0.000 claims description 5
- 240000004713 Pisum sativum Species 0.000 claims description 5
- 238000013519 translation Methods 0.000 claims description 5
- 235000007319 Avena orientalis Nutrition 0.000 claims description 4
- 235000007558 Avena sp Nutrition 0.000 claims description 4
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- 244000017020 Ipomoea batatas Species 0.000 claims description 3
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 3
- 240000003183 Manihot esculenta Species 0.000 claims description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 238000013518 transcription Methods 0.000 claims description 3
- 230000035897 transcription Effects 0.000 claims description 3
- 241000209763 Avena sativa Species 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 39
- 239000002299 complementary DNA Substances 0.000 description 28
- 239000013598 vector Substances 0.000 description 20
- 229920000945 Amylopectin Polymers 0.000 description 19
- 239000012634 fragment Substances 0.000 description 18
- 239000002609 medium Substances 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 16
- 230000009466 transformation Effects 0.000 description 16
- 239000013615 primer Substances 0.000 description 15
- 230000036961 partial effect Effects 0.000 description 14
- 239000000499 gel Substances 0.000 description 13
- 108010039811 Starch synthase Proteins 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 9
- 241000219315 Spinacia Species 0.000 description 8
- 235000009337 Spinacia oleracea Nutrition 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 229930027917 kanamycin Natural products 0.000 description 7
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
- 229960000318 kanamycin Drugs 0.000 description 7
- 229930182823 kanamycin A Natural products 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229920001218 Pullulan Polymers 0.000 description 5
- 239000004373 Pullulan Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000008488 polyadenylation Effects 0.000 description 5
- 235000019423 pullulan Nutrition 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 101100341236 Arabidopsis thaliana ISA2 gene Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000589158 Agrobacterium Species 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical class [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 239000002361 compost Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 3
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 3
- 229940023877 zeatin Drugs 0.000 description 3
- 108090000344 1,4-alpha-Glucan Branching Enzyme Proteins 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 101710091688 Patatin Proteins 0.000 description 2
- 108700001094 Plant Genes Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008049 TAE buffer Substances 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 239000003617 indole-3-acetic acid Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- 102000003925 1,4-alpha-Glucan Branching Enzyme Human genes 0.000 description 1
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- 239000005971 1-naphthylacetic acid Substances 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 101100029764 Arabidopsis thaliana PIA1 gene Proteins 0.000 description 1
- 101100029765 Arabidopsis thaliana PIA2 gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000195585 Chlamydomonas Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108091060211 Expressed sequence tag Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 239000005980 Gibberellic acid Substances 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 101000648528 Homo sapiens Transmembrane protein 50A Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 229920002387 Phytoglycogen Polymers 0.000 description 1
- 108091036407 Polyadenylation Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101000831691 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Transmembrane 9 superfamily member 1 Proteins 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 102100028770 Transmembrane protein 50A Human genes 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 229920002486 Waxy potato starch Polymers 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 101150056604 dbe gene Proteins 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000008223 ribosides Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000011869 shoot development Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2451—Glucanases acting on alpha-1,6-glucosidic bonds
- C12N9/2457—Pullulanase (3.2.1.41)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2451—Glucanases acting on alpha-1,6-glucosidic bonds
- C12N9/246—Isoamylase (3.2.1.68)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01041—Pullulanase (3.2.1.41)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01068—Isoamylase (3.2.1.68)
Definitions
- This invention relates to novel nucleotide sequences, nucleic acid constructs and host cells and organisms comprising said sequences, methods of altering plants using the sequences, and to products obtainable from the altered plants.
- Starch the major storage reserve in plants, consists of two main polysaccharides, amylose and amylopectin.
- Amylose is a linear polymer containing ⁇ -1,4 linked glucose units
- amylopectin is a highly branched polymer consisting of a ⁇ -1,4 linked glucan backbone with ⁇ -1,6 linked glucan branches.
- amylopectin constitutes about 75% of the starch content.
- starch synthases which elongate the glucan chains
- SBE starch branching enzymes
- Debranching enzymes hydrolyse the ⁇ l-6-glucosidic linkages of ⁇ -glucan polymers and are classified into two types depending on their substrate specificities: (1) pullulanases (EC 3.2.1.41 , which are known in plants as "R- enzymes") which act on amylopectin and puUulan (a linear bacterial polymer consisting of 1-6 linked maltotriose units) but which cannot use glycogen as a substrate; and (2) isoamylases (EC 3.2.1.68) which act on amylopectin and glycogen but cannot use puUulan as a substrate.
- pullulanases EC 3.2.1.41 , which are known in plants as "R- enzymes”
- puUulan a linear bacterial polymer consisting of 1-6 linked maltotriose units
- Pullulanases have been purified from a number of plants including maize, rice, sorghum, oat, broad bean, potato, sugarbeet and spinach and the corresponding cDNA clones of maize, rice and spinach have been isolated (James et al 1995; Nakamura et al 1996; Renz et al 1995). In potato, both R-enzyme and isoamylase enzyme polypeptides have been characterised and purified (Drummond et al 1970; Ishizaki,Y et al 1983). A recent publication (WO 95/04826) detailed the purification and peptide sequence determination of a pullulanase type DBE.
- a cDNA encoding a potato DBE was described in a second patent application (WO 96/19581) which detailed the isolation of a partial length (492 bp) cDNA clone encoding a pullulanase type DBE, as well as the effect of downregulating the expression of this gene in transgenic antisense plants.
- An unspecified number of lines were generated and some showed a decrease in debranching enzyme activity (not quantitated) which also led to a slight modification in the swelling characteristics of the starch as measured by RVA (Rapid Viscoamylograph).
- the present application relates particularly to the isolation of nucleic acid sequences encoding potato debranching enzymes (especially isoamylase type debranching enzymes) and to the uses thereof.
- the invention provides a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene.
- DBE isoamylase-type debranching enzyme
- the nucleic acid sequence will comprise at least one region which is characteristic of isoamylase-type debranching enzymes and which is not present in pullulanase type debranching enzymes.
- the nucleic acid sequence will preferably be at least 200bp long, more preferably at least 300-600bp long. Conveniently the sequence is one which is derived or obtained from potato plants.
- the nucleic acid sequence of the invention may be, for instance, a genomic sequence, or may be a cDNA sequence.
- the nucleic acid sequence of the invention may comprise non- coding portions (which are transcribed, but not translated), and/or may comprise coding portions, which are translated into amino acid residues in the full length native gene. As described below, either translated or non-translated portions may be useful in certain techniques, and both therefore possess utility.
- the nucleic acid sequence comprises nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8, or a functional equivalent thereof.
- This sequence includes a portion encoding the amino acid sequence MDWF/YNH, which portion is typically present in the nucleic acid sequences of the invention.
- Functionally equivalent nucleic acid sequences include sequences which encode substantially the same polypeptide, but which differ in nucleotide sequence from mat shown in Figure 8 by virtue of the degeneracy of the genetic code.
- a nucleic acid sequence may be altered (e.g.
- nucleotide sequence differs substantially whilst the amino acid sequence of the encoded polypeptide is unchanged.
- functionally equivalent nucleic acid sequences are those- which will hybridise under stringent hybridisation -conditions (e.g..as- described by Sambrook et al, Molecular Cloning. A Laboratory Manual, CSH, i.e. washing with O. lxSSC, 0.5% SDS at 68°C) with the sequence shown in Figure 8.
- Figures_6A-7B illustrate some related sequences, which are also in accordance with the present invention. These are genomic sequences with large stretches of intron sequence, which introns are not represented in rnRNA. The sequences illustrated in Figures 6A-7B thus comprise both coding and non-coding portions.
- DNA sequences functionally equivalent to that shown in Figure 8 will preferably comprise at least 200, more preferably 300-600bp, and typically will exhibit at least 85% identity (preferably at least 90%, and more preferably at least 95% identity) with the corresponding region of the DNA sequence shown in Figure 8.
- Those skilled in the an will readily be able to conduct a sequence alignment between the putative functionally equivalent sequence and that detailed in Figure 8 - the identity of the two sequences is to be compared in those regions which are aligned by standard computer software, which aligns corresponding regions of the sequences.
- the invention provides a replicable nucleic acid construct comprising the nucleic acid sequence of the first aspect defined above.
- the construct may typically comprise a selectable marker (e.g. kanamycin or hygromycin-resistance) and may allow for transcription (and possibly translation) of the nucleic acid sequence of the invention.
- a selectable marker e.g. kanamycin or hygromycin-resistance
- the construct will comprise a promoter (especially a promoter sequence operable in a plant and/or a promoter operable in a bacterial cell), and one or more regulatory signals (such as polyadenylation signals) known to those skilled in the art.
- the nucleic acid sequence of the invention can be introduced into plants which express a homologous sequence encoding an isoamylase enzyme, in such a way that the introduced sequence interferes with the expression of the homologous sequence.
- the nucleic acid sequence of the invention may be operably linked in the antisense orientation to a suitable promoter active in the plant into which the sequence is to be introduced, so as to reduce the levels of expression of the homologous isoamylase enzyme present in the plant-. _ -
- sense suppression can also occur (i.e. expression of an introduced sequence operably linked in the sense orientation can interfere, by some unknown mechanism, with the expression of the homologous, native gene), as described by Matzke & Matzke (1995 Plant Physiol. 107, 679-685). Any one of the methods mentioned by Matzke & Matzke could, in theory, be used to affect the expression in a host of a homologous isoamylase gene.
- antisense methods are mainly operable by the production of antisense mRNA which hybridises to the sense mRNA, preventing its translation into functional polypeptide, possibly by causing the hybrid RNA to be degraded (e.g. Sheehy et al, 1988 PNAS 55, 8805-8809; Van der Krol et al, Mol. Gen. Genet. 220, 204-212).
- Sense suppression also requires homology between the introduced sequence and the target gene, but the exact mechanism is unclear.
- nucleic acid used will comprise at least 300-600bp of sequence, but by simple trial and error other fragments (smaller or larger) may be found which are functional in altering the characteristics of the plant.
- the invention provides a method of altering a plant by inhibiting the expression of an isoamylase gene therein, the method comprising introducing into the plant the nucleic acid sequence of the invention, operably linked (in the sense or anti-sense orientation) to a promoter active in the plant, wherein the isoamylase gene in the plant has homology to the introduced sequence.
- the introduced nucleic acid will typically comprise at least 200bp, more preferably 300-600bp of sequence having at least 80% (advantageously at least 85%, desirably over 90%) sequence identity with the native isoamylase gene(s) present in the plant.
- the " plant will be a plant which normally comprises large amounts oi J starch, such as potato, sweet potato, maize, wheat, barley, oat, cassava, pea, rice and the like. It is probable that the greater the homology between the introduced sequence and the native gene, the greater the inhibition of expression of the native gene.
- the plant is therefore a potato plant, and/or a plant which has a reduced amylose content (e.g. the "waxy” mutation of potato or the "LAM” [low amylose mutant] strain of pea).
- Inhibition of the isoamylase gene might be expected to affect the properties of the starch present in the plant. In particular it might be expected to result in a starch having increased branching and/or shorter chain length. The obtaining of starch having such properties is a particular object of the present invention.
- nucleic acid sequences may also be advantageous to introduce into the plant one or more additional nucleic acid sequences, especially sequences which might also be expected to have an effect on synthesis and/or metabolism of starch in the plant.
- Particularly preferred are sequences which inhibit the expression of a pullulanase debranching enzyme in the plant.
- Plant pullulanase sequences are known to those skilled in the art (e.g. WO 96/19581), and a portion of a potato pullulanase cDNA sequence is also disclosed herein.
- the additional nucleic acid sequence will typically be homologous to a portion of a native gene in the plant and, as described above, may be introduced into the plant operably linked to a suitable promoter in either the sense or the anti-sense orientation.
- the introduced sequence of the invention and the one or more additional sequences may be operably linked to a single promoter (which would ensure both sequences were transcribed at essentially the same time), or may be operably linked to separate promoters (which may be necessary for optimal expression). Where separate promoters are employed they may be identical to each other or different. Suitable promoters are well known to those skilled in the art and include both constitutive and inducible types. Examples include the CaMV 35S promoter (e.g. single or tandem repeat) and the GBSS type I or patatin promoters of potato.
- the promoter will be tissue-specific. Desirably the promoter will cause expression of the operably linked sequence at substantial levels only in the tissue of the plant where starch synthesis and/or starch storage mainly occurs. Thus, for " example, where the sequence is introduced into a potato plant, the * operably linked promoter may be tuber-specific, such as the patatin promoter.
- nucleic acid sequences may be present on the same nucleic acid plant transformation vector as the portion of isoamylase-encoding sequence, or may be introduced on separate vectors (for example by re-transformation).
- sequence of the invention, and the one or more additional sequences if desired, can be introduced into the plant by any one of a number of well-known techniques (e.g. Agrobacterium-mediated transformation, or by "biolistic" methods).
- the invention provides a plant cell, or a plant or the progeny thereof, which has been altered by the method defined above.
- Altered plant cells, into which the sequence of the invention has been introduced may be grown into plantlets by conventional methods well-known to those skilled in the an.
- the progeny of an altered plant may be obtained, for example, by vegetative propagation, or by crossing the altered plant and reserving the seed so obtained.
- the invention also provides pans of the altered plant, such as storage organs.
- the invention provides tubers comprising altered starch, said tubers being obtained from an altered plant or the progeny thereof.
- the invention also provides a method of obtaining starch from an altered plant, the plant being obtained by the method defined above.
- Starch may be extracted from the plant by any of the known techniques (e.g. milling).
- the invention further provides starch obtainable from a plant altered by the method defined above, the starch having altered propenies compared to starch extracted from an equivalent but unaltered plant.
- the altered starch is obtained from an altered plant selected from the group consisting of cassava, potato, pea, tomato, maize, wheat, barley, oat, sweet potato and rice.
- the altered starch will have an increased degree of branching and/or reduced amylopectin chain length, compared to starch extracted from an equivalent but unaltered plant.
- such altered starch obtained by means of the present invention is found to possess different viscosity charcteristics compared to starch extracted from equivalent, but unaltered, plants.
- the inventors have found that starch obtained from plants altered by the method of the invention may have reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument, (available from Newport Scientific, Sydney, Australia) according to the manufacturer's standard stirring and heating protocol.
- the altered starch may have higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, (as determined, for example, by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument). Further, the altered starch may have an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, (as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument).
- peak viscosity is well known and understood by the person skilled in the art.
- the viscosity of starch preparations is generally investigated by heating an aqueous sample of the starch under controlled conditions of temperature increase, temperature maintenance, and subsequent temperature decrease and with controlled stirring, using an instrument known as a Visco analyser, which produces a viscosity profile called a "viscoamylograph".
- the "peak viscosity” is the maximum viscosity which is attained during the temperature increase phase.
- setback viscosity is the viscosity obtained at the end of the viscoamylograph.
- the viscosity onset temperature is the temperature at which a sudden increase of viscosity is apparent on the viscoamylograph.
- an "equivalent, but unaltered” plant may be considered as a plant which has a substantially identical genotype to a plant altered by the method of the invention, except for the introduced sequences present in the altered plant of the invention. Also to be considered as an equivalent but unaltered plant are those plants which comprise the introduced sequence but wherein the introduced sequence has not affected the starch properties of the plant.
- the invention provides a nucleic acid sequence encoding at least a portion of a potato pullulanase type debranching enzyme, the sequence comprising- substantially nucleotides 46-774 of the nucleic acid sequence shown in Figure 10, or a functional equivalent thereof.
- the term "functional equivalent” should be interpreted as explained previously, but with reference (in this aspect of the invention) to Figure 10 rather than Figure 8.
- the invention provides nucleic acid constructs, and altered host plant cells and organisms, comprising the pullulanase-type DBE nucleic acid sequence defined immediately above.
- Figure 1 shows a comparison of the known amino acid sequences of various putative isoamylase proteins.
- the shaded area indicates residues (single letter amino acid code) that are identical to the maize protein. Dashes indicate gaps introduced to maximise the alignment. Although the whole sequences were compared, only the most conserved region is shown. Sequences are identified at the right; A10906_l is an artificial sequence, A37035 is from a Pseudomonas species SMP1, HIU32761 is from Haemophilus influenzae, ISOA_PSESP is from Pseudomonas amylodermosa and ZMU18908_1 is from Zea mays (corn);
- Figures 2A and 2B show a comparison of the 5' and 3' ends (respectively) of two partial pullulanase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
- Figures 3A and 3B show the DNA sequence (SEQ. ID. NO.s 1 and 4 respectively) and predicted intron exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 2 and 3) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
- Figures 4A and 4B show the DNA sequence (SEQ. ID. NO.s 5 and 8 respectively) and- predicted intron/exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 6 and 7) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
- Figures 5 A and 5B show a comparison of the 5' and 3' ends (respectively) of two partial isoamylase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
- Figures 6 A and 6B show the DNA sequence (SEQ. ID. NO.s 9 and 11 respectively) and predicted intron/exon strucmre, including predicted amino acid sequence (SEQ. ID. NO. 10) at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
- Figures 7A and 7B show the DNA sequence (SEQ. ID. NO.s 12 and 13 respectively) and predicted intron/exon strucmre at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
- Figure 8 shows the DNA sequence (SEQ. ID. NO. 14), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 15) of a partial length potato debranching enzyme (isoamylase) cDNA clone (pSJ132, described below); nucleotides 79-1595, including the poly(A) tail, are isoamylase, the other sequence is derived from pT7Blue vector;
- Figure 9 is a schematic representation of the plant transformation vector pSJ138.
- Figure 10 shows the DNA sequence (SEQ. ID. NO. 16), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 17) of a pullulanase type partial length potato debranching enzyme cDNA clone (pSJ98, described below); nucleotides 46-774 are DBE, the other sequence is derived from pT7Blue vector;
- Figure 11 is a schematic representation of a "double" plant transformation vector, comprising partial isoamylase- and pullulanase-type debranching enzyme sequences operably linked in the anti-sense orientation to separate GBSS promoters;
- Figure 12 shows a zymogram (using a 5% polyacrylamide gel containing 1 % amylopectin) of mber extracts from potato lines transformed with an antisense isoamylase construct in accordance with the invention.
- Figure 13 shows viscosity (RVA) profiles of starch from potato lines transformed with an antisense isoamylase construct, and from a wild type control (1302).
- Example 1 Isolation of a partial cDNA clone of a potato isoamylase.
- PDBE2 ATC AAA TCT/G A/GAA nCC ATC DBE1 ATG GAT GTT GT(T/C/A) TA/TC/T AAT/C CAT
- Genomic DNA was isolated from potato leaves using a modified CTAB (cetyltrimethyl ammonium bromide) method (Murray and Thompson, 1980).
- Leaf tissue (4 gm) was frozen in liquid nitrogen and ground in a mortar and pestle and transferred to a 50 ml polypropylene centrifuge tube (Falcon) to which was added 40 ml of extraction buffer ( 2% w/v CTAB, 100 mM Tris-HCl pH 8.0, 1.4 M NaCl, 10 mM 3-mercaptoefhanol and 20 mM EDTA) and incubated at 65°C for 30 min.
- extraction buffer 2% w/v CTAB, 100 mM Tris-HCl pH 8.0, 1.4 M NaCl, 10 mM 3-mercaptoefhanol and 20 mM EDTA
- the mixture was split into two tubes and 15 ml of chloroform was added to each followed by gentle (end over end) mixing for 15 min at room temperature.
- the tubes were then centrifuged for 5 min at 5000g and the pooled aqueous phases were re-extracted with 5 ml of chloroform.
- the DNA was then precipitated by incubating on ice for 30 minutes with an equal volume of isopropanol and centrifuged for 5 minutes at 3000g. The pellet was washed once with 70% ethanol, briefly air-dried and resuspended in TE pH 8.0 containing 20 ⁇ g ml RNase A.
- the DNA was extracted with 5ml of chloroform, one tenth volume of 3 M sodium acetate (NaAc) pH 5.2 was added and the DNA precipitated with two volumes of ethanol. After centrifugation and washing as above, the DNA was resuspended in 2 ml of TE buffer at pH 8.0 and estimated to be approximately 150 ng/ ⁇ l by fluorometric measurement.
- oligonucleotide primers were made corresponding to these sequences (DBE2 & DBE1 respectively, see above), taking into consideration the codon usage in plant genes in order to reduce the degeneracy of the primers. These were used in a PCR reaction using first strand cDNA from leaf or tuber RNA or genomic DNA as template.
- Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. One clone of each of the 5 PCR fragments was sequenced from either end and in one direction only, therefore the sequence cannot be guaranteed 100 % correct.
- the exon sequences of the 1.8 and 1.6 kb bands (clones #43 & #34, designated pSJ134 and pSJ135 respectively) were found to be identical to pSJ98 (a pullulanase type DBE partial clone, described below) indicating that they are pullulanase type debranching enzymes.
- the two clones pSJ134 and pSJ135 are not identical, sharing 96.3% identity over the entire sequence at the 5' end, and 89.8% identity over 160 nucleotides at the 3' end, after which the two sequences diverge.
- Figure 2 A shows a comparison of the sequences of clones 134 and 135 at their 5' ends
- Figure 2B shows a comparison of their sequences at the 3' end
- Figures 3 A and 3B illustrate the presumed intron exon structure of the 5' and 3' ends (respectively) of clone 134
- Figures 4A and 4B illustrate the presumed intron exon structure of the 5' and 3' ends respectively of clone 135.
- two exons can be distinguished, separated by a 101 bp intron and the remainder of the exon sequences are present in the 3 ' end.
- FIG. 1 shows a comparison of the 5' ends of these clones, whilst Figure 5B compares their 3' ends. As with the pullulanase clones, clones 133 and 137 were not identical (96 and 97% identity at the 5' and 3' ends respectively).
- Figures 6A and 6B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 133.
- Figures 7A and 7B illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 137. Only one intron can be distinguished at each end.
- the 0.8 kb clone although it had the correct primers on both ends was not a debranching enzyme but had homology to a rice Expressed Sequence Tag (RICR2232A) which encodes a 70kDa endomembrane protein.
- a new sense primer (PIAl) was designed to the isoamylase sequences just downstream of the DBE1 primer and this was use in a 3 'RACE PCR to clone the 3' end of the isoamylase gene.
- Five ⁇ l of first strand cDNA and 25 pmol of each primer (PIAl and Ro) were used in a 50 ⁇ l PCR reaction (94°C 2 min followed by 30 cycles of 94°C 45 seconds, 55°C 25 seconds, 72°C 2 min).
- One ⁇ l of this reaction was then used in a second PCR amplification using- PIAl and R, primers.
- a major band of approx 1.5 kb (the expected size) was amplified from both leaf and mber cDNA templates.
- the mber PCR fragment was purified on a 1% TAE agarose gel and then cloned in pT7Blue (clone designated pSJ132), The sequence and predicted ORF of this partial length clone is shown in Figure 8.
- the ORF contains 429 aa and is 77.0% identical to the maize isoamylase protein encoded by the sugary- 1 gene (data not shown).
- a plant transformation vector with the hygromycin selectable marker was constructed in which the 1.5 kb isoamylase cDNA from plasmid pSJ132 was inserted in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter. This vector (pSJ138) was then used to transform wild type and waxy potato plants.
- GBSS granule bound starch synthase
- a plant transformation vector (pSJ138) was constructed by inserting the 1.5 kb isoamylase cDNA from plasmid pSJ132 (as an Xba l-Sac I fragment) in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter into the plant transformation vector pSJ39 which had been cut with the same enzymes.
- GBSS granule bound starch synthase
- pSJ39 is a modified GPTV-HYG vector (Becker et al 1992) containing a 0.8 kb GBSS promoter and was constructed as follows: first the BamHI site between the hygromycin selectable marker and the gene 7 polyadenylation signal in pGPTV-HYG was destroyed by cutting and filling in with klenow polymerase to create pSJ35.
- Hfndlll-EcoRI fragment of this vector (containing the GUS gene & nos polyadenylation signal) was replaced with the H dlll- EcoRI fragment (containing the GBSS promoter-GUS-nos poly(A) cassette) from plasmid pGB121 (obtained from R Visser, Wageningen) to create plasmid pSJ39.
- Transformed potato plants cv Desiree were produced by co-cultivation of explants with Agrobacterium tumefaciens LBA 4404 containing plant transformation vector plasmids. Two explant types were used, microtubers and leaf fragments, both produced from stock cultures, requiring different methods in culture. Stocks of plantlets were maintained of wild type untransformed Desiree or selected lines previously transformed with antisense genes coding for enzymes of the starch biosynthetic pathway by regular transfer of single node explants using Murashige and Skoog media (1962 Physiol. Plant 15, 473) solidified with 0.8% agar with the sucrose concentration reduced from 3% to 1%.
- Microtuber explants were produced by transferring nodes to the same medium with the sucrose concentration increased to 8% plus the addition of 2.5mg/l benzylaminopurine. All cultures were grown at 22°C with illumination from fluorescent tubes at 40 ⁇ E/sqm for 16 hours, except those cltures grown to produce microtubers, which were kept in darkness.
- the protocol for microtuber explants, and that for leaf explants are detailed below.
- Explants were initially precultured on the appropriate multiplication medium for two days before co-cultivation. Co-cultivation was for 10 minutes in an overnight culture of the Agrobacterium before explants were blotted on filter paper to remove excess bacteria. After blotting explants were transferred to filter paper on feeder layers and incubated in darkness at 22°C for two days.
- the feeder layers consisted of a 9cm petri dish containing the appropriate multiplication media covered by 2ml of stationary phase tobacco suspension culture cells which were in turn covered by two layers filter paper.
- Tissue culture and selection using microtuber explants was performed as follows. Microtubers were taken from stock when they were sufficiently large and mature to use. This occurred after 6-8 weeks from transfer of nodes to the high sucrose medium when they weighed more than 30mg and had started to turn from white to pink. Stocks were used for several months after mber initiation provided they remained dormant and no new shoots or stolons had emerged from the bud end. Each tuber was cut in half longitudinally through the terminal bud and the cut end put in contact with the medium.
- the multiplication medium (Z5) used contained the salts and vitamins of Murashige and Skoog plus 3% sucrose, 0.2mg/l indole acetic acid, 5 mg/1 zeatin and 0.8% agar.
- Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 15mg/l when HPTII was used.
- the explants were transferred to fresh medium every two weeks. Explants had two transfers on medium Z5, followed by one transfer on the same medium, except indole acetic acid and zeatin were replaced by lOmg/1 of gibberellic acid (medium MSG). At each transfer all shoots were removed and discarded. The final transfer was to hormone- free Murashige and Skoog medium with the sucrose concentration reduced from 3% to 1%. Shoots were allowed to develop at this stage. Tissue culture and selection using leaf explants was performed as follows.
- the multiplication medium used contained the salts and vitamins of Murashige and Skoog medium " plus 1.6% glucose, 0.02 mg/1 naphthyl acetic acid, 2mg/l zeatin * riboside and 0.8% agar. Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 5mg/l when HPTII was used. Cultures were transferred every two weeks to the same medium. After four transfers the cultures which were vitrified or showed poor shoot development were transferred to liquid Murashige and Skoog medium containing 1.6% sucrose only.
- Transformation was confirmed as follows. Shoots which developed from either mber of leaf explants after the multiplication/organogenesis phase were transferred individually to hormone-free Murashige and Skoog medium containing 1% sucrose and 100 mg/1 kanamycin or 15mg/l hygromycin depending on the selection which was used. Only one shoot was taken from each explant unless the origin of separate shoots were well separated on the explant. Shoots which rooted on selection within two weeks were transferred to the same medium without selection and given an identifying number. When growth allowed sufficient tissue to be sampled, DNA was extracted from a few mgs of leaf and stem tissue of the culture using the method published by Edwards et al (1991 Nucleic Acids Research 19,(6) 1349) and transformation was confirmed by PCR using gene specific primers. Material was left in culture to allow individual shoots to be micropropagated. Positive shoots were micropropagated to be stored in vitro and also to provide planting material.
- Representative samples of the mbers were stored for analysis and .possible regrowth and' 150-200g fresh weight was taken for starch extraction.
- Washed mbers were diced and homogenised to a juice by passage through a Braun MP 75 centrifugal juicer.
- the juice was diluted with tap water to a volume of approximately 3L in a 5L conical flask. After 30 minutes the unsedimented supernatant liquid was discarded and the remaining solids washed again with a further 3L of water. After a further 30 minutes the liquid was decanted and discarded.
- the slurry of solids was poured through a 500 ⁇ m metal mesh filter which retained the bulk of the cell debris.
- the crude starch which passed through the filter was washed in the same manner until no protein foam remained and only white starch settled on the base of the flask below a clear supernatant liquid.
- the starch was harvested on filter paper using a Buchner funnel and washed on the funnel with two 500ml volumes of distiled water. Finally the starch was washed with 500ml of acetone and dried in a fume hood for approximately 30 minutes
- the degree of branching of the starches was determined by ⁇ NMR spectroscopy (Gidley
- Example 3 Cloning of a pullulanase type debranching enzyme from potato.
- a PCR based cloning strategy was devised for isolating pullulanase type debranching enzymes from potato, using conserved domains within the known cloned gene sequences, of which spinach was the only plant gene (genbank SOPULSPO_l).
- the amino acid sequence DGFRFDLMG was almost completely conserved (data not shown) and this is found at aa 546-554 of the spinach protein (964 aa in total). It was hoped therefore that this would also be present in the potato gene, as the sequence DGFRFD is also completely conserved in plant starch branching enzyme genes which belong to the same superfamily of amylolytic genes.
- Peptide sequences from the purified potato debranching enzyme which were published in WO 95/04826 were also compared to the spinach sequence; of the 12 peptide sequences 10 made possible matches to the spinach sequence and of these peptide number 1 (RTLLVNLDSDDVKPEGGDNL. corresponding to aa 300-319 of the-spinach sequence,' identical residues underlined) was chosen to make a degenerate oligonucleotide sense primer (PDBEl ;20mer,64x) to be used in PCR with a degenerate antisense primer designed to the sequence DGFRFD (PDBE2; 18mer, 16x). These primers were used in a PCR reaction with mber or leaf first strand cDNA as template.
- cDNA Five ⁇ l of cDNA was used as template in a 50 ⁇ l PCR reaction with 50 pmol of each degenerate primer (PDBEl & 2) under standard PCR conditions (28 cycles of 94°C 45 seconds, 48°C 25 seconds, 72°C 90 seconds).
- the PCR products were separated on a 1% agarose gel in TAE buffer.
- a strong band of the expected size (672bp) was amplified from the mber cDNA and a much weaker band from the leaf cDNA.
- the mber amplified band was cut out and purified by binding to DEAE paper and then cloned in the pT7Blue vector (Novagen).
- a diagram of the resulting vector is shown in Figure 11. In Figure 11, the symbols used have the same meanings as in Figure 9: pA-CaMV is the CaMV polyadenylation signal. This vector may then be used to transform potato plants, substantially as described in Example 2.
- zymograms are usually used to determine the presence or absence of debranching enzymes. Protein extracts were separated on native 5% polyacrylamide gels containing 1% potato amylopectin. After separation the gel was incubated for 1-3 hours in 100 mM citrate buffer pH 5.5 containing 10 mM EDTA, 1 mM acarbose, and 2.5 mM DTT. The gel was then rinsed twice in deionized water and stained with iodine (Lugol's solution). Debranching enzymes stain as blue bands against a purple background, whereas amylases appear as clear bands.
- the debranching enzyme bands in the amylopectin gel can thus be classified into isoamylase bands (which do not appear in the red pullulan containing gel) and pullulanase bands (which give clear bands in red pullulan containing gels).
- RVA Rotary Visco Analyser
- Viscosity development of starches was analysed using a Rapid Visco Analyser Series 4 instrument (Newport Scientific, Sydney, Australia). For the 13 minute profile, 2 g of starch was weighed into a sample cup and 25 ml of water was added to give a final starch concentration of 7.4 % (w/v) and the analysis was performed using the standard stirring and heating protocol according to the manufacturer's instructions. Viscosity was measured in centipoise (cP).
- Figure 13 shows the viscosity profiles of tuber starches from plants transformed with the antisense isoamylase construct.
- the linear plot shows the temperature profile.
- a wild type control line 1302, unbroken thin line
- Starch from line 1352 solid thick curve
- Starch from line 1352 shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level
- lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level (lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line).
- the viscosity onset temperature is slightly increased for line
- the latter PCR fragment (492 bp) was isolated using primers derived from the sequence of a genomic clone which hybridised to a degenerate oligonucleotide very similar to the PDBEl oligo which was used in the experiments described here.
- the deduced amino acid sequence of the PCR fragment did not correspond exactly to the two peptide sequences from the purified protein (RTLLVNLDSDDVKPEGGDNL, SEQ. ID. NO. 30; and RLSSAGITHVHLLPTYNFA, SEQ. ID. NO. 31; differences are shown underlined).
- the inventors have also cloned two PCR fragments (2.4 and 2.0 kb; pSJ133 and 137 respectively) from genomic DNA of potato which have significant homology to isoamylase genes. These clones differ in the size, and perhaps number, of introns and are about 96-97% identical ( Figure 4), suggesting that they are derived from different genes.
- a cDNA fragment of approx 1500 bp was obtained by 3 'RACE; this cDNA encodes 429 aa which are 77% identical to the maize isoamylase gene and the inventors are confident that this gene is an isoamylase type DBE.
- the two different isoamylase-type DBE genomic sequences isolated by the inventors relate to two different genes having slightly different functions or roles in the potato plant, and that similar multiple isoamylase-type genes exist in other plants. Different isoamylase-type genes might, for instance, be subjected- to different regulatory * controls. As the genomic sequences recovered are not full length genes, it is possible that the respective gene sequences may diverge in the uncloned portions.
- pullulanase and isoamylase genes appear to be expressed in mbers and leaves since PCR bands of the correct size can be amplified from either mber or leaf first strand cDNA templates. The intensity of the amplified band is stronger in mbers for both DBE, possibly indicating that the expression level of both genes is higher in mbers, but this should be confirmed by northern analysis.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Disclosed is a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase enzyme gene, together with constructs and host cells comprising the nucleic acid sequence, and methods of using the nucleic acid sequence.
Description
Title : Improvements in or Relating to Stability of Plant Starches
Field of the Invention
This invention relates to novel nucleotide sequences, nucleic acid constructs and host cells and organisms comprising said sequences, methods of altering plants using the sequences, and to products obtainable from the altered plants.
Background of the Invention
Starch, the major storage reserve in plants, consists of two main polysaccharides, amylose and amylopectin. Amylose is a linear polymer containing α-1,4 linked glucose units, while amylopectin is a highly branched polymer consisting of a α-1,4 linked glucan backbone with α-1,6 linked glucan branches. In most plant storage reserves, including tubers, amylopectin constitutes about 75% of the starch content. Until recently it was thought that amylopectin was synthesized by the concerted action of two enzymes: starch synthases, which elongate the glucan chains; and starch branching enzymes (SBE), which introduce branches to create amylopectin. It was further considered that it is the chain length specificity of the branching enzymes that determines the starch structure (Tolmasky & Krisman, 1987). Support for this hypothesis was provided by the characterisation of maize (Takeda et al 1993) and pea SBE (Burton et al 1995).
An alternative hypothesis which is gaining support, suggests that debranching enzymes play an important role in the synthesis of amylopectin and hence starch structure (Ball et al 1996; Nakamura,Y. 1996). The evidence for this comes mainly from an analysis of two mutants: sugary 1 mutants of maize synthesise a highly branched water soluble polysaccharide called phytoglycogen and have a defect in a debranching enzyme (Pan and Nelson 1984; James et al 1995) and a recently characterised mutant (STA7) of Chlamydomonas , which has a dramatic effect on starch synthesis, was shown to have a severe reduction in the activity of a debranching enzyme (Mouille et al 1996).
It is desirable to be able to increase the degree of branching and/or reduce the chain length of the amylopectin in starches, especially waxy potato starches, in order to create more freeze/ thaw-stable starches. Very recently, it has been reported that overexpressing the E. coli glycogen branching enzyme in a waxy (i.e. amylose-free). potato does lead to a ' increase in the degree of branching of amylopectin (Kortsee et al 1996). However, the increase in branching was only 25 % , and the average chain length of the amylopectin was decreased only marginally - by 3 glucose units (from 25 to 22 glucose residues). An alternative approach to obtain a more highly-modified starch would be to decrease the expression of debranching enzymes in the potato tuber using an antisense or sense- suppression approach. To do this efficiently requires the cloning of a cDNA copy of a potato debranching enzyme.
Debranching enzymes (DBΕ) hydrolyse the αl-6-glucosidic linkages of α-glucan polymers and are classified into two types depending on their substrate specificities: (1) pullulanases (EC 3.2.1.41 , which are known in plants as "R- enzymes") which act on amylopectin and puUulan (a linear bacterial polymer consisting of 1-6 linked maltotriose units) but which cannot use glycogen as a substrate; and (2) isoamylases (EC 3.2.1.68) which act on amylopectin and glycogen but cannot use puUulan as a substrate.
Pullulanases have been purified from a number of plants including maize, rice, sorghum, oat, broad bean, potato, sugarbeet and spinach and the corresponding cDNA clones of maize, rice and spinach have been isolated (James et al 1995; Nakamura et al 1996; Renz et al 1995). In potato, both R-enzyme and isoamylase enzyme polypeptides have been characterised and purified (Drummond et al 1970; Ishizaki,Y et al 1983). A recent publication (WO 95/04826) detailed the purification and peptide sequence determination of a pullulanase type DBE. A cDNA encoding a potato DBE was described in a second patent application (WO 96/19581) which detailed the isolation of a partial length (492 bp) cDNA clone encoding a pullulanase type DBE, as well as the effect of downregulating the expression of this gene in transgenic antisense plants. An unspecified number of lines were generated and some showed a decrease in debranching enzyme activity (not quantitated) which also led to a slight modification in the swelling characteristics of the starch as measured by RVA (Rapid Viscoamylograph). These included a decrease in the
maximum viscosity to about half of the control, and an increase in the setback viscosity (from 3300 cP in the control to 5200 in the most highly-modified plant line). No significant change in the amylose/amylopectin ratio was observed but there was an increase in the phosphate content of the starch (from 9 to 14.6 nmol G6P/mg starch). - '
The present application relates particularly to the isolation of nucleic acid sequences encoding potato debranching enzymes (especially isoamylase type debranching enzymes) and to the uses thereof.
Summary of the Invention
In a first aspect the invention provides a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene. Those skilled in the art will appreciate that the nucleic acid sequence will comprise at least one region which is characteristic of isoamylase-type debranching enzymes and which is not present in pullulanase type debranching enzymes. The nucleic acid sequence will preferably be at least 200bp long, more preferably at least 300-600bp long. Conveniently the sequence is one which is derived or obtained from potato plants.
The nucleic acid sequence of the invention may be, for instance, a genomic sequence, or may be a cDNA sequence. The nucleic acid sequence of the invention may comprise non- coding portions (which are transcribed, but not translated), and/or may comprise coding portions, which are translated into amino acid residues in the full length native gene. As described below, either translated or non-translated portions may be useful in certain techniques, and both therefore possess utility.
In a particular embodiment, the nucleic acid sequence comprises nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8, or a functional equivalent thereof. (This sequence includes a portion encoding the amino acid sequence MDWF/YNH, which portion is typically present in the nucleic acid sequences of the invention). Functionally equivalent nucleic acid sequences include sequences which encode substantially the same polypeptide, but which differ in nucleotide sequence from mat shown in Figure 8 by virtue of the degeneracy of the genetic code. For example, a nucleic acid sequence may be
altered (e.g. "codon optimised") for expression in a particular host cell or host organism, such that the nucleotide sequence differs substantially whilst the amino acid sequence of the encoded polypeptide is unchanged. Typically, functionally equivalent nucleic acid sequences are those- which will hybridise under stringent hybridisation -conditions (e.g..as- described by Sambrook et al, Molecular Cloning. A Laboratory Manual, CSH, i.e. washing with O. lxSSC, 0.5% SDS at 68°C) with the sequence shown in Figure 8. Figures_6A-7B illustrate some related sequences, which are also in accordance with the present invention. These are genomic sequences with large stretches of intron sequence, which introns are not represented in rnRNA. The sequences illustrated in Figures 6A-7B thus comprise both coding and non-coding portions.
DNA sequences functionally equivalent to that shown in Figure 8 will preferably comprise at least 200, more preferably 300-600bp, and typically will exhibit at least 85% identity (preferably at least 90%, and more preferably at least 95% identity) with the corresponding region of the DNA sequence shown in Figure 8. Those skilled in the an will readily be able to conduct a sequence alignment between the putative functionally equivalent sequence and that detailed in Figure 8 - the identity of the two sequences is to be compared in those regions which are aligned by standard computer software, which aligns corresponding regions of the sequences.
In a second aspect the invention provides a replicable nucleic acid construct comprising the nucleic acid sequence of the first aspect defined above. The construct may typically comprise a selectable marker (e.g. kanamycin or hygromycin-resistance) and may allow for transcription (and possibly translation) of the nucleic acid sequence of the invention. Conveniently therefore the construct will comprise a promoter (especially a promoter sequence operable in a plant and/or a promoter operable in a bacterial cell), and one or more regulatory signals (such as polyadenylation signals) known to those skilled in the art.
The nucleic acid sequence of the invention can be introduced into plants which express a homologous sequence encoding an isoamylase enzyme, in such a way that the introduced sequence interferes with the expression of the homologous sequence. Thus, for example,
the nucleic acid sequence of the invention may be operably linked in the antisense orientation to a suitable promoter active in the plant into which the sequence is to be introduced, so as to reduce the levels of expression of the homologous isoamylase enzyme present in the plant-. _ -
Additionally, it has recently been demonstrated in other experimental systems that "sense suppression" can also occur (i.e. expression of an introduced sequence operably linked in the sense orientation can interfere, by some unknown mechanism, with the expression of the homologous, native gene), as described by Matzke & Matzke (1995 Plant Physiol. 107, 679-685). Any one of the methods mentioned by Matzke & Matzke could, in theory, be used to affect the expression in a host of a homologous isoamylase gene.
It has been found in some experimental systems that there is no requirement for translation of the introduced sequence in order for an inhibitory effect to be observed, and it is believed that antisense methods are mainly operable by the production of antisense mRNA which hybridises to the sense mRNA, preventing its translation into functional polypeptide, possibly by causing the hybrid RNA to be degraded (e.g. Sheehy et al, 1988 PNAS 55, 8805-8809; Van der Krol et al, Mol. Gen. Genet. 220, 204-212). Sense suppression also requires homology between the introduced sequence and the target gene, but the exact mechanism is unclear. It is apparent that, in relation to both antisense and sense suppression, neither a full length nucleotide sequence, nor a "native" sequence (i.e. the introduced sequence need not be 100% identical to the sequence of the homologous native gene) is essential. Preferably the nucleic acid used will comprise at least 300-600bp of sequence, but by simple trial and error other fragments (smaller or larger) may be found which are functional in altering the characteristics of the plant.
Accordingly, in a third aspect the invention provides a method of altering a plant by inhibiting the expression of an isoamylase gene therein, the method comprising introducing into the plant the nucleic acid sequence of the invention, operably linked (in the sense or anti-sense orientation) to a promoter active in the plant, wherein the isoamylase gene in the plant has homology to the introduced sequence. The introduced nucleic acid will typically comprise at least 200bp, more preferably 300-600bp of sequence having at least
80% (advantageously at least 85%, desirably over 90%) sequence identity with the native isoamylase gene(s) present in the plant.
Advantageously the "plant will be a plant which normally comprises large amounts oi J starch, such as potato, sweet potato, maize, wheat, barley, oat, cassava, pea, rice and the like. It is probable that the greater the homology between the introduced sequence and the native gene, the greater the inhibition of expression of the native gene. Preferably the plant is therefore a potato plant, and/or a plant which has a reduced amylose content (e.g. the "waxy" mutation of potato or the "LAM" [low amylose mutant] strain of pea).
Inhibition of the isoamylase gene might be expected to affect the properties of the starch present in the plant. In particular it might be expected to result in a starch having increased branching and/or shorter chain length. The obtaining of starch having such properties is a particular object of the present invention.
It may also be advantageous to introduce into the plant one or more additional nucleic acid sequences, especially sequences which might also be expected to have an effect on synthesis and/or metabolism of starch in the plant. Particularly preferred are sequences which inhibit the expression of a pullulanase debranching enzyme in the plant. Plant pullulanase sequences are known to those skilled in the art (e.g. WO 96/19581), and a portion of a potato pullulanase cDNA sequence is also disclosed herein. The additional nucleic acid sequence will typically be homologous to a portion of a native gene in the plant and, as described above, may be introduced into the plant operably linked to a suitable promoter in either the sense or the anti-sense orientation.
The introduced sequence of the invention and the one or more additional sequences may be operably linked to a single promoter (which would ensure both sequences were transcribed at essentially the same time), or may be operably linked to separate promoters (which may be necessary for optimal expression). Where separate promoters are employed they may be identical to each other or different. Suitable promoters are well known to those skilled in the art and include both constitutive and inducible types. Examples include the CaMV 35S promoter (e.g. single or tandem repeat) and the GBSS
type I or patatin promoters of potato. Advantageously the promoter will be tissue-specific. Desirably the promoter will cause expression of the operably linked sequence at substantial levels only in the tissue of the plant where starch synthesis and/or starch storage mainly occurs. Thus, for "example, where the sequence is introduced into a potato plant, the* operably linked promoter may be tuber-specific, such as the patatin promoter.
Those skilled in the art will also appreciate that, if additional nucleic acid sequences are to be introduced into the plant, they may be present on the same nucleic acid plant transformation vector as the portion of isoamylase-encoding sequence, or may be introduced on separate vectors (for example by re-transformation). The sequence of the invention, and the one or more additional sequences if desired, can be introduced into the plant by any one of a number of well-known techniques (e.g. Agrobacterium-mediated transformation, or by "biolistic" methods).
In another aspect, the invention provides a plant cell, or a plant or the progeny thereof, which has been altered by the method defined above. Altered plant cells, into which the sequence of the invention has been introduced, may be grown into plantlets by conventional methods well-known to those skilled in the an. The progeny of an altered plant may be obtained, for example, by vegetative propagation, or by crossing the altered plant and reserving the seed so obtained. The invention also provides pans of the altered plant, such as storage organs. Conveniently, for example, the invention provides tubers comprising altered starch, said tubers being obtained from an altered plant or the progeny thereof.
The invention also provides a method of obtaining starch from an altered plant, the plant being obtained by the method defined above. Starch may be extracted from the plant by any of the known techniques (e.g. milling). The invention further provides starch obtainable from a plant altered by the method defined above, the starch having altered propenies compared to starch extracted from an equivalent but unaltered plant. Conveniently the altered starch is obtained from an altered plant selected from the group consisting of cassava, potato, pea, tomato, maize, wheat, barley, oat, sweet potato and rice. Typically the altered starch will have an increased degree of branching and/or
reduced amylopectin chain length, compared to starch extracted from an equivalent but unaltered plant. In general, such altered starch obtained by means of the present invention is found to possess different viscosity charcteristics compared to starch extracted from equivalent, but unaltered, plants. In particular, the inventors have found that starch obtained from plants altered by the method of the invention may have reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument, (available from Newport Scientific, Sydney, Australia) according to the manufacturer's standard stirring and heating protocol. Alternatively, or additionally, the altered starch may have higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, (as determined, for example, by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument). Further, the altered starch may have an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, (as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument).
The terms "peak viscosity", "setback viscosity" and "viscosity onset temperature" are well known and understood by the person skilled in the art. By way of explanation for the novice reader, the viscosity of starch preparations is generally investigated by heating an aqueous sample of the starch under controlled conditions of temperature increase, temperature maintenance, and subsequent temperature decrease and with controlled stirring, using an instrument known as a Visco analyser, which produces a viscosity profile called a "viscoamylograph". The "peak viscosity" is the maximum viscosity which is attained during the temperature increase phase. The "setback viscosity" is the viscosity obtained at the end of the viscoamylograph. The viscosity onset temperature is the temperature at which a sudden increase of viscosity is apparent on the viscoamylograph.
For the purposes of the present invention, an "equivalent, but unaltered" plant may be considered as a plant which has a substantially identical genotype to a plant altered by the method of the invention, except for the introduced sequences present in the altered plant of the invention. Also to be considered as an equivalent but unaltered plant are those plants which comprise the introduced sequence but wherein the introduced sequence has
not affected the starch properties of the plant.
In a further aspect, the invention provides a nucleic acid sequence encoding at least a portion of a potato pullulanase type debranching enzyme, the sequence comprising- substantially nucleotides 46-774 of the nucleic acid sequence shown in Figure 10, or a functional equivalent thereof. The term "functional equivalent" should be interpreted as explained previously, but with reference (in this aspect of the invention) to Figure 10 rather than Figure 8.
Similarly, the invention provides nucleic acid constructs, and altered host plant cells and organisms, comprising the pullulanase-type DBE nucleic acid sequence defined immediately above.
The invention will now be further described by way of illustrative example and with reference to the accompanying drawings, in which:
Figure 1 shows a comparison of the known amino acid sequences of various putative isoamylase proteins. The shaded area indicates residues (single letter amino acid code) that are identical to the maize protein. Dashes indicate gaps introduced to maximise the alignment. Although the whole sequences were compared, only the most conserved region is shown. Sequences are identified at the right; A10906_l is an artificial sequence, A37035 is from a Pseudomonas species SMP1, HIU32761 is from Haemophilus influenzae, ISOA_PSESP is from Pseudomonas amylodermosa and ZMU18908_1 is from Zea mays (corn);
Figures 2A and 2B show a comparison of the 5' and 3' ends (respectively) of two partial pullulanase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
Figures 3A and 3B show the DNA sequence (SEQ. ID. NO.s 1 and 4 respectively) and predicted intron exon structure, including predicted amino acid sequences (SEQ. ID. NO.s
2 and 3) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
Figures 4A and 4B-show the DNA sequence (SEQ. ID. NO.s 5 and 8 respectively) and- predicted intron/exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 6 and 7) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
Figures 5 A and 5B show a comparison of the 5' and 3' ends (respectively) of two partial isoamylase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
Figures 6 A and 6B show the DNA sequence (SEQ. ID. NO.s 9 and 11 respectively) and predicted intron/exon strucmre, including predicted amino acid sequence (SEQ. ID. NO. 10) at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
Figures 7A and 7B show the DNA sequence (SEQ. ID. NO.s 12 and 13 respectively) and predicted intron/exon strucmre at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
Figure 8 shows the DNA sequence (SEQ. ID. NO. 14), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 15) of a partial length potato debranching enzyme (isoamylase) cDNA clone (pSJ132, described below); nucleotides 79-1595, including the poly(A) tail, are isoamylase, the other sequence is derived from pT7Blue vector;
Figure 9 is a schematic representation of the plant transformation vector pSJ138;
Figure 10 shows the DNA sequence (SEQ. ID. NO. 16), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 17) of a
pullulanase type partial length potato debranching enzyme cDNA clone (pSJ98, described below); nucleotides 46-774 are DBE, the other sequence is derived from pT7Blue vector;
Figure 11 is a schematic representation of a "double" plant transformation vector, comprising partial isoamylase- and pullulanase-type debranching enzyme sequences operably linked in the anti-sense orientation to separate GBSS promoters;
Figure 12 shows a zymogram (using a 5% polyacrylamide gel containing 1 % amylopectin) of mber extracts from potato lines transformed with an antisense isoamylase construct in accordance with the invention; and
Figure 13 shows viscosity (RVA) profiles of starch from potato lines transformed with an antisense isoamylase construct, and from a wild type control (1302).
EXAMPLES
Example 1 : Isolation of a partial cDNA clone of a potato isoamylase.
Throughout the examples described in the present specification, standard procedures were performed essentially according to Sambrook et al (1989). DNA sequencing was performed on an ABI automated DNA sequencer and sequences manipulated using DNASTAR software for the Macintosh computer.
Oligonucleotides
The following oligonucleotides (SEQ ID. NO.s 18-29 respectively) were employed in the examples described below:
RoRidT!7 AAG GAT CCG TCG AC A TCG ATA ATA CGA CTC ACT ATA GGGA(T17)
Ro AAG GAT CCG TCG ACA TC
Ri GAC ATC GAT AAT ACG AC
PDBE1 GAC/T GAC/T GTn AAA G CCT GAA/G GG
PDBE2 ATC AAA TCT/G A/GAA nCC ATC
DBE1 ATG GAT GTT GT(T/C/A) TA/TC/T AAT/C CAT
DBE2 TCA AAA/T CG/TA/G AAi CCA TC
PIA1 GAG GCA TTG AC A AC A GTG TG
"PIA2 CGT GAC ATG GTA CGG CAG TT
PIA3 AAC TGC CGT ACC ATG TCA CG
PIA4 GGT TAT AGA TGG CAG CCG TT
PIA5 AAC GGC TGC CAT CTA TAA CC
Potato DNA isolation
Genomic DNA was isolated from potato leaves using a modified CTAB (cetyltrimethyl ammonium bromide) method (Murray and Thompson, 1980). Leaf tissue (4 gm) was frozen in liquid nitrogen and ground in a mortar and pestle and transferred to a 50 ml polypropylene centrifuge tube (Falcon) to which was added 40 ml of extraction buffer ( 2% w/v CTAB, 100 mM Tris-HCl pH 8.0, 1.4 M NaCl, 10 mM 3-mercaptoefhanol and 20 mM EDTA) and incubated at 65°C for 30 min. After cooling, the mixture was split into two tubes and 15 ml of chloroform was added to each followed by gentle (end over end) mixing for 15 min at room temperature. The tubes were then centrifuged for 5 min at 5000g and the pooled aqueous phases were re-extracted with 5 ml of chloroform. The DNA was then precipitated by incubating on ice for 30 minutes with an equal volume of isopropanol and centrifuged for 5 minutes at 3000g. The pellet was washed once with 70% ethanol, briefly air-dried and resuspended in TE pH 8.0 containing 20 μg ml RNase A. After incubation at room temperamre for 30 minutes the DNA was extracted with 5ml of chloroform, one tenth volume of 3 M sodium acetate (NaAc) pH 5.2 was added and the DNA precipitated with two volumes of ethanol. After centrifugation and washing as above, the DNA was resuspended in 2 ml of TE buffer at pH 8.0 and estimated to be approximately 150 ng/μl by fluorometric measurement.
RNA isolation and cDNA synthesis
RNA was isolated from potato plants by the method of Logemann et al (1987). Tuber material consisted of small tubers (<1 gm ) harvested from a mature plant. Leaf material was from source leaves (>10 cm) of a healthy vigorously growing plant from the greenhouse. Five microgram of RNA was heated in water for 3 minutes at 65°C and then
reverse transcribed in a 50 μl reaction using 10 pmol of RoRidT17 as primer and MMLV reverse transcriptase (Stratascript 50 units; reaction conditions 50mM Tris-HCl (pH 8. 3), 75mM KC1, lOmM DTT, 3mM MgCl2, 0.5mM each dNTP, lU/μl RNasin and incubation for 1 hour at 37°C); The reaction was then diluted to 200 μl with TE-pH 8.0 and stored^ at 4°C.
Isoamylase cloning
No amino acid sequence information for isoamylase enzymes from potato was publicly available at the time this work was performed, therefore the cloning strategy relied only on conserved sequence regions among known or putative isoamylase type debranching enzymes from other sources. As shown in Figure 1, there are two regions within isoamylase proteins that are conserved. One of these is the same DGFRFD sequence found in the pullulanase enzymes (see example 3) and the second (MDWFΥNH) is found approx 70 aa from this sequence towards the N-terminus. Degenerate oligonucleotide primers were made corresponding to these sequences (DBE2 & DBE1 respectively, see above), taking into consideration the codon usage in plant genes in order to reduce the degeneracy of the primers. These were used in a PCR reaction using first strand cDNA from leaf or tuber RNA or genomic DNA as template.
Approximately 50ng of potato genomic DNA or 5μl of first strand cDNA were used as template in a 50μl PCR reaction containing 25pmol of each degenerate primer (DBE1 & 2) under standard PCR conditions (30 cycles of 94°C 60 seconds, 50°C 60 seconds, 72°C 60 seconds). The PCR products were separated on a 1% agarose gel in TAE buffer. The expected size fragment (240 bp) was amplified from both leaf and tuber cDNA templates although the signal was stronger in the latter. However when genomic DNA was used as template, 5 strong bands of approx 2.4, 2.0, 1.8, 1.6 and 0.6 kb were amplified indicating that intron(s) are present within this portion of the genes. This pattern was very reproducible and only occurred when both primers were used in the PCR reaction. These 5 bands were cut out and purified using Qiaquick columns (Qiagen) and then cloned in the pT7Blue vector (Novagen).
Colonies were screened by PCR and positives were grown up and DNA isolated from a 50
ml culture by alkaline lysis and PEG precipitation. One clone of each of the 5 PCR fragments was sequenced from either end and in one direction only, therefore the sequence cannot be guaranteed 100 % correct.
The exon sequences of the 1.8 and 1.6 kb bands (clones #43 & #34, designated pSJ134 and pSJ135 respectively) were found to be identical to pSJ98 (a pullulanase type DBE partial clone, described below) indicating that they are pullulanase type debranching enzymes. The two clones pSJ134 and pSJ135 are not identical, sharing 96.3% identity over the entire sequence at the 5' end, and 89.8% identity over 160 nucleotides at the 3' end, after which the two sequences diverge. Figure 2 A shows a comparison of the sequences of clones 134 and 135 at their 5' ends, whilst Figure 2B shows a comparison of their sequences at the 3' end. Figures 3 A and 3B illustrate the presumed intron exon structure of the 5' and 3' ends (respectively) of clone 134. Similarly, Figures 4A and 4B illustrate the presumed intron exon structure of the 5' and 3' ends respectively of clone 135. In both clones, at the 5' end two exons can be distinguished, separated by a 101 bp intron and the remainder of the exon sequences are present in the 3 ' end.
The 2.4 and 2.0 kb bands (clones #44 & #42, designated pSJ133 and pSJ137 respectively) showed most homology to the isoamylase genes (data not shown). Figure 5 A shows a comparison of the 5' ends of these clones, whilst Figure 5B compares their 3' ends. As with the pullulanase clones, clones 133 and 137 were not identical (96 and 97% identity at the 5' and 3' ends respectively). Figures 6A and 6B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 133. Similarly, Figures 7A and 7B illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 137. Only one intron can be distinguished at each end.
The 0.8 kb clone, although it had the correct primers on both ends was not a debranching enzyme but had homology to a rice Expressed Sequence Tag (RICR2232A) which encodes a 70kDa endomembrane protein.
A new sense primer (PIAl) was designed to the isoamylase sequences just downstream of the DBE1 primer and this was use in a 3 'RACE PCR to clone the 3' end of the isoamylase
gene. Five μl of first strand cDNA and 25 pmol of each primer (PIAl and Ro) were used in a 50 μl PCR reaction (94°C 2 min followed by 30 cycles of 94°C 45 seconds, 55°C 25 seconds, 72°C 2 min). One μl of this reaction was then used in a second PCR amplification using- PIAl and R, primers. A major band of approx 1.5 kb (the expected size) was amplified from both leaf and mber cDNA templates. The mber PCR fragment was purified on a 1% TAE agarose gel and then cloned in pT7Blue (clone designated pSJ132), The sequence and predicted ORF of this partial length clone is shown in Figure 8. The ORF contains 429 aa and is 77.0% identical to the maize isoamylase protein encoded by the sugary- 1 gene (data not shown).
Example 2: Transformation of plants with antisense isoamylase
A plant transformation vector with the hygromycin selectable marker was constructed in which the 1.5 kb isoamylase cDNA from plasmid pSJ132 was inserted in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter. This vector (pSJ138) was then used to transform wild type and waxy potato plants.
Construction of plant transformation vector
A plant transformation vector (pSJ138) was constructed by inserting the 1.5 kb isoamylase cDNA from plasmid pSJ132 (as an Xba l-Sac I fragment) in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter into the plant transformation vector pSJ39 which had been cut with the same enzymes. pSJ39 is a modified GPTV-HYG vector (Becker et al 1992) containing a 0.8 kb GBSS promoter and was constructed as follows: first the BamHI site between the hygromycin selectable marker and the gene 7 polyadenylation signal in pGPTV-HYG was destroyed by cutting and filling in with klenow polymerase to create pSJ35. The Hfndlll-EcoRI fragment of this vector (containing the GUS gene & nos polyadenylation signal) was replaced with the H dlll- EcoRI fragment (containing the GBSS promoter-GUS-nos poly(A) cassette) from plasmid pGB121 (obtained from R Visser, Wageningen) to create plasmid pSJ39. Plasmid pGB121 was constructed by inserting the 0.8 kb GBSS promoter from genomic clone LGBSSwt-6 (Visser et al 1989) as an Hinάlll-Nsil (klenow filled in) fragment into the Ht/zdIII-ΛtI(T4 DNA polymerase blunted) sites of plasmid pBI121 (Jefferson et al 1987). Construction of pSJ138 is illustrated schematically in Figure 9.
In Figure 9 the black line represents the DNA sequence. The hashed line represents the bacterial plasmid backbone (containing the origin of replication and bacterial selection marker) and is not shown in full. The filled triangles represent the T-DNA borders (RB = right border and LB = left border). Relevant restriction enzyme sites are shown above- the black line with the approximate distances (in kilobases kb) between sites marked by an asterisk shown underneath. The thinnest arrows represent polyadenylation signals (pA-nos = nopaline synthase, pAg7 = Agrobacterium gene 7), the intermediate arrows denote protein coding regions (HYG = hyromcin resistance gene etc) and the thick arrows indicate promoter regions (P-GBSS = granule bound starch synthase and P-nos = nopaline synthase).
Potato transformation protocol
Transformed potato plants cv Desiree were produced by co-cultivation of explants with Agrobacterium tumefaciens LBA 4404 containing plant transformation vector plasmids. Two explant types were used, microtubers and leaf fragments, both produced from stock cultures, requiring different methods in culture. Stocks of plantlets were maintained of wild type untransformed Desiree or selected lines previously transformed with antisense genes coding for enzymes of the starch biosynthetic pathway by regular transfer of single node explants using Murashige and Skoog media (1962 Physiol. Plant 15, 473) solidified with 0.8% agar with the sucrose concentration reduced from 3% to 1%. Microtuber explants were produced by transferring nodes to the same medium with the sucrose concentration increased to 8% plus the addition of 2.5mg/l benzylaminopurine. All cultures were grown at 22°C with illumination from fluorescent tubes at 40μE/sqm for 16 hours, except those cltures grown to produce microtubers, which were kept in darkness. The protocol for microtuber explants, and that for leaf explants (based ona modification of that published by Rocha-Sosa et al 1989, EMBO J. 8, 23), are detailed below.
Explants were initially precultured on the appropriate multiplication medium for two days before co-cultivation. Co-cultivation was for 10 minutes in an overnight culture of the Agrobacterium before explants were blotted on filter paper to remove excess bacteria. After blotting explants were transferred to filter paper on feeder layers and incubated in darkness at 22°C for two days. The feeder layers consisted of a 9cm petri dish containing
the appropriate multiplication media covered by 2ml of stationary phase tobacco suspension culture cells which were in turn covered by two layers filter paper.
After two days the explants were removed and washed in Murashige and Skoog medium' (without sucrose or agar) containing 500μg/ml cefataxime, blotted on filter paper and transferred to multiplication medium containing 500μg/ml cefataxime. After a further five days the explants were further transferred to the same medium containing the selection agent. Selection was effected by the use of the NPTII gene in the construct and addition of kanamycin in the tissue culture process or the HPTII gene with additions of hygromycin. To achieve double transformations lines resistant to kanamycin containing the NPTII gene and a gene to modulate starch biosynthesis were subsequently transformed with a construct containing the HPTII using hygromycin selection. This was reversed if the line used had been originally transformed with a HPTII containing construct and NPTII and kanamycin were used for selection.
Tissue culture and selection using microtuber explants was performed as follows. Microtubers were taken from stock when they were sufficiently large and mature to use. This occurred after 6-8 weeks from transfer of nodes to the high sucrose medium when they weighed more than 30mg and had started to turn from white to pink. Stocks were used for several months after mber initiation provided they remained dormant and no new shoots or stolons had emerged from the bud end. Each tuber was cut in half longitudinally through the terminal bud and the cut end put in contact with the medium. The multiplication medium (Z5) used contained the salts and vitamins of Murashige and Skoog plus 3% sucrose, 0.2mg/l indole acetic acid, 5 mg/1 zeatin and 0.8% agar. Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 15mg/l when HPTII was used. The explants were transferred to fresh medium every two weeks. Explants had two transfers on medium Z5, followed by one transfer on the same medium, except indole acetic acid and zeatin were replaced by lOmg/1 of gibberellic acid (medium MSG). At each transfer all shoots were removed and discarded. The final transfer was to hormone- free Murashige and Skoog medium with the sucrose concentration reduced from 3% to 1%. Shoots were allowed to develop at this stage.
Tissue culture and selection using leaf explants was performed as follows. Expanded leaves were taken from stock cultures and cut into fragments comprising a half or a third of the leaf. The multiplication medium used contained the salts and vitamins of Murashige and Skoog medium" plus 1.6% glucose, 0.02 mg/1 naphthyl acetic acid, 2mg/l zeatin* riboside and 0.8% agar. Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 5mg/l when HPTII was used. Cultures were transferred every two weeks to the same medium. After four transfers the cultures which were vitrified or showed poor shoot development were transferred to liquid Murashige and Skoog medium containing 1.6% sucrose only.
Transformation was confirmed as follows. Shoots which developed from either mber of leaf explants after the multiplication/organogenesis phase were transferred individually to hormone-free Murashige and Skoog medium containing 1% sucrose and 100 mg/1 kanamycin or 15mg/l hygromycin depending on the selection which was used. Only one shoot was taken from each explant unless the origin of separate shoots were well separated on the explant. Shoots which rooted on selection within two weeks were transferred to the same medium without selection and given an identifying number. When growth allowed sufficient tissue to be sampled, DNA was extracted from a few mgs of leaf and stem tissue of the culture using the method published by Edwards et al (1991 Nucleic Acids Research 19,(6) 1349) and transformation was confirmed by PCR using gene specific primers. Material was left in culture to allow individual shoots to be micropropagated. Positive shoots were micropropagated to be stored in vitro and also to provide planting material.
Growth of Transformed Lines
Five plants from each line, when 50- 100mm high, were transferred to compost made up of 50% horticultural sand and 50% Levington F2 peat-based compost in 20mm square modular pots and maintained at 20°C (day) and 15°C (night) in a growth room illuminated for 16 hours with high pressure sodium lamps at an illumination of 400 μE/sq m. After watering they were covered within a small propagator and shaded from illumination. After 7-10 days when new growth was apparent the shading was removed and the plants grown on, with an intermediate potting to 70mm diameter pots. Finally the five plants were grown to maturity together in a 250mm diameter pot in Levington F2 compost under glass.
Sixteen to eighteen weeks after transfer from culture when the foliage began to die down all the mbers were harvested.
Representative samples of the mbers were stored for analysis and .possible regrowth and' 150-200g fresh weight was taken for starch extraction.
Starch extraction
Washed mbers were diced and homogenised to a juice by passage through a Braun MP 75 centrifugal juicer. The juice was diluted with tap water to a volume of approximately 3L in a 5L conical flask. After 30 minutes the unsedimented supernatant liquid was discarded and the remaining solids washed again with a further 3L of water. After a further 30 minutes the liquid was decanted and discarded. The slurry of solids was poured through a 500μm metal mesh filter which retained the bulk of the cell debris. The crude starch which passed through the filter was washed in the same manner until no protein foam remained and only white starch settled on the base of the flask below a clear supernatant liquid. The starch was harvested on filter paper using a Buchner funnel and washed on the funnel with two 500ml volumes of distiled water. Finally the starch was washed with 500ml of acetone and dried in a fume hood for approximately 30 minutes.
Starch analysis
The degree of branching of the starches was determined by Η NMR spectroscopy (Gidley
1985), and more detailed analysis performed as dscribed in example 5 below.
Example 3: Cloning of a pullulanase type debranching enzyme from potato.
A PCR based cloning strategy was devised for isolating pullulanase type debranching enzymes from potato, using conserved domains within the known cloned gene sequences, of which spinach was the only plant gene (genbank SOPULSPO_l). The amino acid sequence DGFRFDLMG was almost completely conserved (data not shown) and this is found at aa 546-554 of the spinach protein (964 aa in total). It was hoped therefore that this would also be present in the potato gene, as the sequence DGFRFD is also completely conserved in plant starch branching enzyme genes which belong to the same superfamily of amylolytic genes.
Peptide sequences from the purified potato debranching enzyme which were published in WO 95/04826 were also compared to the spinach sequence; of the 12 peptide sequences 10 made possible matches to the spinach sequence and of these peptide number 1 (RTLLVNLDSDDVKPEGGDNL. corresponding to aa 300-319 of the-spinach sequence,' identical residues underlined) was chosen to make a degenerate oligonucleotide sense primer (PDBEl ;20mer,64x) to be used in PCR with a degenerate antisense primer designed to the sequence DGFRFD (PDBE2; 18mer, 16x). These primers were used in a PCR reaction with mber or leaf first strand cDNA as template.
Five μl of cDNA was used as template in a 50 μl PCR reaction with 50 pmol of each degenerate primer (PDBEl & 2) under standard PCR conditions (28 cycles of 94°C 45 seconds, 48°C 25 seconds, 72°C 90 seconds). The PCR products were separated on a 1% agarose gel in TAE buffer. A strong band of the expected size (672bp) was amplified from the mber cDNA and a much weaker band from the leaf cDNA. The mber amplified band was cut out and purified by binding to DEAE paper and then cloned in the pT7Blue vector (Novagen). Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. The resulting plasmid was designated pSJ98 and the sequence is shown in Figure 10. Comparison of this sequence to the spinach gene showed it to be 75.7% identical at the DNA level and 75.5 % at the protein (data not shown). It is concluded therefore that this gene belongs to the pullulanase class of debranching enzymes. In all, three clones of the potato DBE PCR in pT7Blue were sequenced (#4, 5 & 6) #4 = pSJ98, #5 = pSJ136 opposite orientation (17305-506). Clone #6 was found to have a 34bp deletion approx 100 bp from the 5' end, which caused a shift in the reading frame resulting in a truncated polypeptide.
Example 4 Construction of double antisense isoamylase and pullulanase plant transformation vector
A cassette consisting of the 0.7 kb pullulanase type DBE cDNA from pSJ98 in an antisense orientation between the GBSS promoter and CaMV poly A signal (Guerineau et al 1988), was inserted as a blunt fragment into the unique Pme I site of the plant transformation vector pSJ138. A diagram of the resulting vector is shown in Figure 11. In Figure 11, the symbols used have the same meanings as in Figure 9: pA-CaMV is the CaMV
polyadenylation signal. This vector may then be used to transform potato plants, substantially as described in Example 2.
Example 5 Analysis of potato plants transformed with Isoamylase antisense construct (from example 2)
Zymograms
There is no specific assay for debranching enzymes. Therefore zymograms are usually used to determine the presence or absence of debranching enzymes. Protein extracts were separated on native 5% polyacrylamide gels containing 1% potato amylopectin. After separation the gel was incubated for 1-3 hours in 100 mM citrate buffer pH 5.5 containing 10 mM EDTA, 1 mM acarbose, and 2.5 mM DTT. The gel was then rinsed twice in deionized water and stained with iodine (Lugol's solution). Debranching enzymes stain as blue bands against a purple background, whereas amylases appear as clear bands.
In order to distinguish between the two classes of debranching enzymes, isoamylases and pullulanases, a second set of protein extracts was separated on another polyacrylamide gel containing 1% amylopectin. After the run the proteins were transferred onto a 10% polyacrylamide gel containing 1% red pullulan (Megazyme, Wicklow, Ireland) using standard Western blotting apparatus. The red pullulan containing gel was then incubated as described above for the amylopectin containing gel. Pullulanase bands appear as clear bands against the red background. The debranching enzyme bands in the amylopectin gel can thus be classified into isoamylase bands (which do not appear in the red pullulan containing gel) and pullulanase bands (which give clear bands in red pullulan containing gels).
In Figure 12 mber extracts of ten different antisense lines were analysed in a zymogram as described above. The upper band with a low electrophoretic mobility is a debranching enzyme as it stains blue in the amylopectin containing gel against a purple background. By comparison with the band pattern of a red pullulan containing gel (data not shown) it could be demonstrated that this band is not a pullulanase and can therefore be classified as an isoamylase. Transformed potato line 1352 clearly lacks this isoamylase band. In this line
isoamylase expression was successfully inhibited by the antisense construct. The lower band apparent in Figure 12 is an amylase which stains as a clear zone in a purple background. Depending on incubation time, two additional debranching enzyme bands could be detected which are of the pullulanase type and not affected in line 1352.
Analysis of starch by RVA (Rapid Visco Analyser)
In addition to the examination of isoamylase enzyme expression by zymograms, the physical properties of mber starch was analysed, in order to test whether the lack of the isoamylase enzyme alters the starch properties.
Viscosity development of starches was analysed using a Rapid Visco Analyser Series 4 instrument (Newport Scientific, Sydney, Australia). For the 13 minute profile, 2 g of starch was weighed into a sample cup and 25 ml of water was added to give a final starch concentration of 7.4 % (w/v) and the analysis was performed using the standard stirring and heating protocol according to the manufacturer's instructions. Viscosity was measured in centipoise (cP).
Figure 13 shows the viscosity profiles of tuber starches from plants transformed with the antisense isoamylase construct. The linear plot shows the temperature profile. In addition a wild type control (line 1302, unbroken thin line) is shown. Starch from line 1352 (solid thick curve) shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level (lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line). In addition the viscosity onset temperature (pasting temperature) is slightly increased for line 1352. These data clearly indicate that the reduction of isoamylase activity (in line 1352) changes the starch strucmre and composition resulting in novel physico-chemical properties.
Discussion
When this work was started, no cDNA clones of potato debranching enzymes had been reported although some peptide sequences from a purified potato pullulanase were published in patent WO 95/04826. The present inventors were able to clone a partial
length (672 bp) cDNA .clone of a potato pullulanase (pSJ98, Figure 10). A second publication (WO 96/19581) by the authors of WO 95/04826 then described the cloning of a full length cDNA of a spinach DBE (pullulanase type) as well as a PCR fragment of a potato pullulanase." The latter PCR fragment (492 bp) was isolated using primers derived from the sequence of a genomic clone which hybridised to a degenerate oligonucleotide very similar to the PDBEl oligo which was used in the experiments described here. However the deduced amino acid sequence of the PCR fragment did not correspond exactly to the two peptide sequences from the purified protein (RTLLVNLDSDDVKPEGGDNL, SEQ. ID. NO. 30; and RLSSAGITHVHLLPTYNFA, SEQ. ID. NO. 31; differences are shown underlined). The authors of WO 96/19581 concluded that this was a result of the protein being purified from the variety Desiree whereas the cDNA library was constructed from the variety Berolina. However, the peptide sequences also do not match exactly the sequence of pSJ98 (which was isolated from Desiree) suggesting that more than one pullulanase type DBE gene exists in potato. This is supported by the comparison the of the two PCR fragments which show only 93.6% identity at the DNA and 90.7% at the protein level with one amino acid insertion in the prior art clone (data not shown).
Further evidence that more than one pullulanase gene exists was provided by the cloning of two PCR fragments (1.8 and 1.6 kb) from genomic DNA (pSJ134 & 135). Sequence obtained from the ends of the clones indicated that they differed in the size of one intron (compare Figures 3A/B and 4A/B). The exon sequence of clone pSJ134 was identical to pSJ98 at the amino acid level but those of pSJ135 differed at one amino acid (results not shown).
The inventors have also cloned two PCR fragments (2.4 and 2.0 kb; pSJ133 and 137 respectively) from genomic DNA of potato which have significant homology to isoamylase genes. These clones differ in the size, and perhaps number, of introns and are about 96-97% identical (Figure 4), suggesting that they are derived from different genes. A cDNA fragment of approx 1500 bp was obtained by 3 'RACE; this cDNA encodes 429 aa which are 77% identical to the maize isoamylase gene and the inventors are confident that this gene is an isoamylase type DBE.
It is possible that the two different isoamylase-type DBE genomic sequences isolated by the inventors relate to two different genes having slightly different functions or roles in the potato plant, and that similar multiple isoamylase-type genes exist in other plants. Different isoamylase-type genes might, for instance, be subjected- to different regulatory* controls. As the genomic sequences recovered are not full length genes, it is possible that the respective gene sequences may diverge in the uncloned portions. It may therefore be desirable to ensure that, in the various methods of the invention defined previously, a single sequence is used which is sufficiently long, and has sufficient homology to both isoamylase-type sequences that expression of both native isoamylase-type genes (if present) is inhibited, or, in the alternative, to ensure that two different sequences are employed to inhibit expression of the respective native isoamylase-type genes. The same comments apply equally to the pullulanase-type sequences discovered by the inventors.
Both pullulanase and isoamylase genes appear to be expressed in mbers and leaves since PCR bands of the correct size can be amplified from either mber or leaf first strand cDNA templates. The intensity of the amplified band is stronger in mbers for both DBE, possibly indicating that the expression level of both genes is higher in mbers, but this should be confirmed by northern analysis.
References
Ball et al., (1996) Cell 86, 349-352.
Becker et al., (1992) Plant Molecular Biology 20, 1195-1197.
Burton et al, (1995) Plant J. 7, 3-15.
Drummond et al, (1970) FEBS Lett 9, 136-140.
Frohman et al, (1988) Proc. Natl. Acad. Sci. USA 85, 8998-9002.
Gidley (1985) Carbohydrate Research 139, 85-93.
Guerineau et al, (1988) Nucl. Acids Res. 16, 11380.
Ishizaki et al, (1983) Agric. Biol. Chem. 47, 771-779.
James et al, (1995) Plant Cell 7, 417-429.
Jefferson et al, (1987) EMBO J. 6, 3901-3907.
Koømann et α/.,(1995) WO 95/04826.
Koβmann et al, (1996) WO 96/19581.
Kortsee et al, (1996) The Plant Journal 10, 83-90.
Logemann et al, (1987) Anal. Biochem. 163, 21-26.
Molulle et al, (1996) Plant Cell 8,1353-1366.
Murray & Thompson (1980) Nucl. Acids Res. 8, 4321- 4325.
Nakamura (1996) Plant Science 121, 1-18.
Nakamura et al, (1996) Planta 199, 209-218.
Pan & Nelson (1984) Plant Physiol. 74, 324-328.
Renz et al, (1995) Genbank accession number X83969.
Sambrook et al, (1989) Molecular cloning: A laboratory manual, 2nd ed. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Tolmasky & Krisman (1987) Eur. J. Biochem. 168, 393-397.
Takeda et al, (1993) Carbohydrate Research 240, 253-263.
Visser et al, (1989) Plant Sci. 64, 185-192.
Claims
1. A nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene. - "
2. A sequence according to claim 1, comprising at least 200bp of an isoamylase gene.
3. A sequence according to claim 1 or 2, comprising at least 300-600bp of an isoamylase
4. A sequence according to any one of claims 1, 2 or 3, comprising substantially any one of the nucleic acid sequences shown in Figures 5A and 5B, or a functional equivalent thereof.
5. A sequence according to any one of claims 1, 2 or 3, comprising substantially any one of the nucleic acid sequences shown in Figures 6A, 6B, 7A and 7B, or a functional equivalent thereof.
6. A sequence according to any one of claims 1, 2 or 3 which, when linked in the sense orientation to a promoter, encodes a polypeptide comprising the amino acid sequence shown in Figure 8.
7. A sequence according to claim 6, comprising substantially nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8. or a functional equivalent thereof.
8. A nucleic acid construct comprising a sequence in accordance with any one of the preceding claims operably linked in the sense or antisense orientation to a promoter active in a plant.
9. A host cell into which has been introduced a sequence in accordance with any one of claims 1-7, or a construct in accordance with claim 8.
10. A plant cell according to claim 9.
1 1. A plantlet grown from a plant cell according to claim 10.
12. A method of altering a plant by inhibiting the expression of an isoamylase therein, the method comprising the steps of: introducing into the plant at least 200bp of a sequence carrying- an isoamylase gene and exhibiting at least 80% identity with a nucleic acid sequence shown in any one of Figures 5A, 5B, 6A, 6B, 7A, 7B or 8, said sequence being operably linked in the sense or antisense orientation to a suitable promoter active in the plant; and causing transcription of the introduced nucleic acid sequence, said transcript and/or the translation product thereof being sufficient to interfere with the expression of a homologous isoamylase gene naturally present in the plant.
13. A method according to claim 12, wherein the plant is: potato, sweet potato, maize, wheat, barley, oat, cassava, pea, or rice.
14. A method according to claim 12 or 13, comprising the introduction of one or more additional nucleic acid sequences, operably linked in the sense or anti-sense orientation to a suitable promoter active in the plant, and causing transcription of the one or more additional nucleic acid sequences, said transcript(s) and/or the translation product(s) thereof being sufficient to interfere with the expression of a homologous gene present in the plant.
15. A method according to claim 14, wherein said additional nucleic acid sequence comprises an effective portion of a pullulanase type debranching enzyme.
16. A method according to claim 14 or 15, wherein the said additional nucleic acid sequence comprises a portion which confers a waxy (i.e. low amylose starch) phenotype on the plant.
17. A method according to any one of claims 12-15, wherein the sequences are introduced into a plant having a waxy (i.e. low amylose starch) phenotype.
18. A method according to any one of claims 12-17, wherein the method results in a plant comprising starch having different properties compared to starch from an equivalent, but unaltered plant.
19. A plant altered by the method of any one of claims 12-18, or the progeny thereof.
20. Starch obtained from a plant according to claim 19, having altered properties compared to starch obtained from an equivalent but unaltered plant.
21. Starch according to claim 20. having increased branching and/or shorter chain length compared to starch extracted from an equivalent but unaltered plant.
22. Starch according to claim 19 or 20, having reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
23. Starch according to any one of claims 19, 20 or 21, having higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
24. Starch according to any one of claims 19-22, having an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
25. A nucleic acid sequence substantially as hereinbefore defined and with reference to the accompanying drawings.
26. A method of altering a plant substantially as hereinbefore defined.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9718863 | 1997-09-06 | ||
| GBGB9718863.5A GB9718863D0 (en) | 1997-09-06 | 1997-09-06 | Improvements in or relating to stability of plant starches |
| PCT/GB1998/002665 WO1999012950A2 (en) | 1997-09-06 | 1998-09-04 | Improvements in or relating to stability of plant starches |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1009751A2 true EP1009751A2 (en) | 2000-06-21 |
Family
ID=10818600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98941593A Withdrawn EP1009751A2 (en) | 1997-09-06 | 1998-09-04 | Improvements in or relating to stability of plant starches |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1009751A2 (en) |
| AU (1) | AU8991198A (en) |
| CA (1) | CA2302639A1 (en) |
| GB (1) | GB9718863D0 (en) |
| WO (1) | WO1999012950A2 (en) |
Families Citing this family (177)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9716185D0 (en) | 1997-07-31 | 1997-10-08 | Innes John Centre | Starch debranching enzymes |
| CL2007003744A1 (en) | 2006-12-22 | 2008-07-11 | Bayer Cropscience Ag | COMPOSITION THAT INCLUDES A 2-PYRIDILMETILBENZAMIDE DERIVATIVE AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY. |
| CL2007003743A1 (en) | 2006-12-22 | 2008-07-11 | Bayer Cropscience Ag | COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY. |
| WO2008110280A2 (en) | 2007-03-12 | 2008-09-18 | Bayer Cropscience Ag | Phenoxy substituted phenylamidine derivatives and their use as fungicides |
| EP1969934A1 (en) | 2007-03-12 | 2008-09-17 | Bayer CropScience AG | 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides |
| US8080688B2 (en) | 2007-03-12 | 2011-12-20 | Bayer Cropscience Ag | 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides |
| EP1969929A1 (en) | 2007-03-12 | 2008-09-17 | Bayer CropScience AG | Substituted phenylamidines and their use as fungicides |
| WO2008110279A1 (en) | 2007-03-12 | 2008-09-18 | Bayer Cropscience Ag | Dihalophenoxyphenylamidines and use thereof as fungicides |
| WO2008128639A1 (en) | 2007-04-19 | 2008-10-30 | Bayer Cropscience Aktiengesellschaft | Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide |
| DE102007045953B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
| DE102007045922A1 (en) | 2007-09-26 | 2009-04-02 | Bayer Cropscience Ag | Drug combinations with insecticidal and acaricidal properties |
| DE102007045956A1 (en) | 2007-09-26 | 2009-04-09 | Bayer Cropscience Ag | Combination of active ingredients with insecticidal and acaricidal properties |
| DE102007045920B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Synergistic drug combinations |
| DE102007045919B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
| EP2090168A1 (en) | 2008-02-12 | 2009-08-19 | Bayer CropScience AG | Method for improving plant growth |
| EP2072506A1 (en) | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide |
| EP2168434A1 (en) | 2008-08-02 | 2010-03-31 | Bayer CropScience AG | Use of azols to increase resistance of plants of parts of plants to abiotic stress |
| EP2321262A1 (en) | 2008-08-14 | 2011-05-18 | Bayer CropScience AG | Insecticidal 4-phenyl-1h-pyrazoles |
| DE102008041695A1 (en) | 2008-08-29 | 2010-03-04 | Bayer Cropscience Ag | Methods for improving plant growth |
| EP2201838A1 (en) | 2008-12-05 | 2010-06-30 | Bayer CropScience AG | Active ingredient-beneficial organism combinations with insecticide and acaricide properties |
| EP2198709A1 (en) | 2008-12-19 | 2010-06-23 | Bayer CropScience AG | Method for treating resistant animal pests |
| EP2204094A1 (en) | 2008-12-29 | 2010-07-07 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants Introduction |
| EP2223602A1 (en) | 2009-02-23 | 2010-09-01 | Bayer CropScience AG | Method for improved utilisation of the production potential of genetically modified plants |
| AU2009335333B2 (en) | 2008-12-29 | 2015-04-09 | Bayer Intellectual Property Gmbh | Method for improved use of the production potential of genetically modified plants |
| EP2039771A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
| EP2039772A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants introduction |
| EP2039770A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
| WO2010081689A2 (en) | 2009-01-19 | 2010-07-22 | Bayer Cropscience Ag | Cyclic diones and their use as insecticides, acaricides and/or fungicides |
| EP2227951A1 (en) | 2009-01-23 | 2010-09-15 | Bayer CropScience AG | Application of enaminocarbonyl compounds for combating viruses transmitted by insects |
| JP5592398B2 (en) | 2009-01-28 | 2014-09-17 | バイエル・クロップサイエンス・アーゲー | Disinfectant N-cycloalkyl-N-bicyclic methylene-carboxamide derivatives |
| AR075126A1 (en) | 2009-01-29 | 2011-03-09 | Bayer Cropscience Ag | METHOD FOR THE BEST USE OF THE TRANSGENIC PLANTS PRODUCTION POTENTIAL |
| EP2218717A1 (en) | 2009-02-17 | 2010-08-18 | Bayer CropScience AG | Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives |
| CN102317259B (en) | 2009-02-17 | 2015-12-02 | 拜尔农科股份公司 | Fungicidal N-(phenylcycloalkyl) carboxylic acid amides, N-(benzylic cycloalkyl group) carboxylic acid amides and thiocarboxamide derivative |
| TW201031331A (en) | 2009-02-19 | 2010-09-01 | Bayer Cropscience Ag | Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance |
| BRPI0924436B1 (en) | 2009-03-25 | 2017-06-06 | Bayer Cropscience Ag | combinations of active substances with insecticidal and acaricidal properties and their use, as well as method for pest and animal control |
| EP2232995A1 (en) | 2009-03-25 | 2010-09-29 | Bayer CropScience AG | Method for improved utilisation of the production potential of transgenic plants |
| EP2410849A1 (en) | 2009-03-25 | 2012-02-01 | Bayer CropScience AG | Active ingredient combinations having insecticidal and acaricidal properties |
| MX2011009372A (en) | 2009-03-25 | 2011-09-27 | Bayer Cropscience Ag | Active ingredient combinations having insecticidal and acaricidal properties. |
| EP2410850A2 (en) | 2009-03-25 | 2012-02-01 | Bayer Cropscience AG | Synergistic combinations of active ingredients |
| US8828906B2 (en) | 2009-03-25 | 2014-09-09 | Bayer Cropscience Ag | Active compound combinations having insecticidal and acaricidal properties |
| EP2239331A1 (en) | 2009-04-07 | 2010-10-13 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
| US8835657B2 (en) | 2009-05-06 | 2014-09-16 | Bayer Cropscience Ag | Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides |
| AR076839A1 (en) | 2009-05-15 | 2011-07-13 | Bayer Cropscience Ag | FUNGICIDE DERIVATIVES OF PIRAZOL CARBOXAMIDAS |
| EP2251331A1 (en) | 2009-05-15 | 2010-11-17 | Bayer CropScience AG | Fungicide pyrazole carboxamides derivatives |
| EP2255626A1 (en) | 2009-05-27 | 2010-12-01 | Bayer CropScience AG | Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress |
| CN105165832B (en) | 2009-06-02 | 2019-08-13 | 拜耳知识产权有限责任公司 | Application of the succinate dehydrogenase inhibitors in control Sclerotinia fungi |
| AU2010272872B2 (en) | 2009-07-16 | 2014-08-28 | Bayer Intellectual Property Gmbh | Synergistic active substance combinations containing phenyl triazoles |
| WO2011015524A2 (en) | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Fungicide heterocycles derivatives |
| EP2292094A1 (en) | 2009-09-02 | 2011-03-09 | Bayer CropScience AG | Active compound combinations |
| EP2343280A1 (en) | 2009-12-10 | 2011-07-13 | Bayer CropScience AG | Fungicide quinoline derivatives |
| US9000012B2 (en) | 2009-12-28 | 2015-04-07 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives |
| MX2012007540A (en) | 2009-12-28 | 2012-07-23 | Bayer Cropscience Ag | Fungicidal hydroximoyl - tetrazole derivatives. |
| US8796463B2 (en) | 2009-12-28 | 2014-08-05 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
| NZ601341A (en) | 2010-01-22 | 2014-02-28 | Bayer Ip Gmbh | Acaricide and/or insecticide active substance combinations |
| WO2011107504A1 (en) | 2010-03-04 | 2011-09-09 | Bayer Cropscience Ag | Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
| BR112012025714A2 (en) | 2010-04-06 | 2015-09-08 | Bayer Ip Gmbh | use of 4-phenylbutyric acid and / or salts thereof to increase plant stress tolerance |
| WO2011124553A2 (en) | 2010-04-09 | 2011-10-13 | Bayer Cropscience Ag | Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress |
| CN102971309A (en) | 2010-04-28 | 2013-03-13 | 拜尔农科股份公司 | Fungicide oxime-heterocyclic derivatives |
| WO2011134911A2 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
| EP2563784A1 (en) | 2010-04-28 | 2013-03-06 | Bayer CropScience AG | Fungicide hydroximoyl-heterocycles derivatives |
| UA110703C2 (en) | 2010-06-03 | 2016-02-10 | Байєр Кропсайнс Аг | Fungicidal n-[(trisubstitutedsilyl)methyl]carboxamide |
| MX2012013897A (en) | 2010-06-03 | 2012-12-17 | Bayer Cropscience Ag | N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues. |
| CA2796194A1 (en) | 2010-06-03 | 2011-12-08 | Bayer Cropscience Ag | N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues |
| RU2639512C2 (en) | 2010-06-09 | 2017-12-21 | Байер Кропсайенс Нв | Methods and means for vegetable genome modification in nucleotide sequence, widely used in plant genomic engineering |
| AU2011264074B2 (en) | 2010-06-09 | 2015-01-22 | Bayer Cropscience Nv | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
| KR20130041225A (en) | 2010-07-20 | 2013-04-24 | 바이엘 크롭사이언스 아게 | Benzocycloalkenes as Antifungal Agents |
| AU2011298423B2 (en) | 2010-09-03 | 2015-11-05 | Bayer Intellectual Property Gmbh | Substituted fused pyrimidinones and dihydropyrimidinones |
| EP2460406A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Use of fluopyram for controlling nematodes in nematode resistant crops |
| BR112013006611B1 (en) | 2010-09-22 | 2021-01-19 | Bayer Intellectual Property Gmbh | method for the control of soy cyst nematode (heterodera glycines) by infesting a nematode resistant soy plant comprising the application of n- {2- [3-chloro-5- (trifluoromethyl) -2-pyridinyl] ethyl} -2 - (trifluoromethyl) benzamide (fluoride |
| US9408391B2 (en) | 2010-10-07 | 2016-08-09 | Bayer Intellectual Property Gmbh | Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative |
| UA107865C2 (en) | 2010-10-21 | 2015-02-25 | Байєр Інтелекчуал Проперті Гмбх | Heterocyclic carboxamides |
| MX2013004286A (en) | 2010-10-21 | 2013-06-05 | Bayer Ip Gmbh | 1-(heterocyclic carbonyl) piperidines. |
| BR112013010683B1 (en) | 2010-11-02 | 2018-06-26 | Bayer Intellectual Property Gmbh | COMPOUND, FUNGICIDE COMPOSITION AND METHOD FOR CONTROLLING PHYTOPATHOGENIC CROP FUNGI |
| US20130231303A1 (en) | 2010-11-15 | 2013-09-05 | Bayer Intellectual Property Gmbh | 5-halogenopyrazole(thio)carboxamides |
| WO2012065944A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | N-aryl pyrazole(thio)carboxamides |
| CN107266368A (en) | 2010-11-15 | 2017-10-20 | 拜耳知识产权有限责任公司 | 5 halo-pyrazole formamides |
| EP2460407A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Agent combinations comprising pyridylethyl benzamides and other agents |
| CN103281900A (en) | 2010-12-01 | 2013-09-04 | 拜耳知识产权有限责任公司 | Use of fluopyram for controlling nematodes in crops and for increasing yield |
| EP2474542A1 (en) | 2010-12-29 | 2012-07-11 | Bayer CropScience AG | Fungicide hydroximoyl-tetrazole derivatives |
| JP2014502611A (en) | 2010-12-29 | 2014-02-03 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | Fungicide hydroxymoyl-tetrazole derivative |
| EP2471363A1 (en) | 2010-12-30 | 2012-07-04 | Bayer CropScience AG | Use of aryl-, heteroaryl- and benzylsulfonamide carboxylic acids, -carboxylic acid esters, -carboxylic acid amides and -carbonitriles and/or its salts for increasing stress tolerance in plants |
| EP2494867A1 (en) | 2011-03-01 | 2012-09-05 | Bayer CropScience AG | Halogen-substituted compounds in combination with fungicides |
| EP2683239A1 (en) | 2011-03-10 | 2014-01-15 | Bayer Intellectual Property GmbH | Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds |
| JP2014509599A (en) | 2011-03-14 | 2014-04-21 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | Fungicide hydroxymoyl-tetrazole derivative |
| EP2694494A1 (en) | 2011-04-08 | 2014-02-12 | Bayer Intellectual Property GmbH | Fungicide hydroximoyl-tetrazole derivatives |
| AR090010A1 (en) | 2011-04-15 | 2014-10-15 | Bayer Cropscience Ag | 5- (CICLOHEX-2-EN-1-IL) -PENTA-2,4-DIENOS AND 5- (CICLOHEX-2-EN-1-IL) -PENT-2-EN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST THE ABIOTIC STRESS OF PLANTS, USES AND TREATMENT METHODS |
| AR085585A1 (en) | 2011-04-15 | 2013-10-09 | Bayer Cropscience Ag | VINIL- AND ALQUINILCICLOHEXANOLES SUBSTITUTED AS ACTIVE PRINCIPLES AGAINST STRIPS ABIOTIQUE OF PLANTS |
| AR085568A1 (en) | 2011-04-15 | 2013-10-09 | Bayer Cropscience Ag | 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENTA-2,4-DIENOS AND 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENT- 2-IN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST ABIOTIC STRESS OF PLANTS |
| EP2511255A1 (en) | 2011-04-15 | 2012-10-17 | Bayer CropScience AG | Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives |
| HRP20160061T1 (en) | 2011-04-22 | 2016-02-12 | Bayer Intellectual Property Gmbh | COMBINATIONS OF ACTIVE COMPOUNDS CONTAINING CARBOXAMIDE DERIVATIVE AND FUNGICIDE COMPOUND |
| CN103597082B (en) | 2011-06-06 | 2017-09-15 | 拜尔作物科学公司 | For the ways and means in preselected site modified plant genome |
| EP2729007A1 (en) | 2011-07-04 | 2014-05-14 | Bayer Intellectual Property GmbH | Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants |
| AU2012293636B2 (en) | 2011-08-10 | 2015-12-03 | Bayer Intellectual Property Gmbh | Active compound combinations comprising specific tetramic acid derivatives |
| EP2748161A1 (en) | 2011-08-22 | 2014-07-02 | Bayer Intellectual Property GmbH | Fungicide hydroximoyl-tetrazole derivatives |
| CN107287234A (en) | 2011-08-22 | 2017-10-24 | 拜尔作物科学公司 | The ways and means of modified plant genome |
| EP2561759A1 (en) | 2011-08-26 | 2013-02-27 | Bayer Cropscience AG | Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth |
| CN103781353B (en) | 2011-09-09 | 2016-10-19 | 拜耳知识产权有限责任公司 | Acyl homoserine lactone derivatives for improving plant yield |
| MX347562B (en) | 2011-09-12 | 2017-05-03 | Bayer Ip Gmbh | Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]met hyl}-1,2,4-oxadizol-5(4h)-one derivatives. |
| CA2848622A1 (en) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Use of 5-phenyl- or 5-benzyl-2-isoxazoline-3-carboxylates for improving plant yield |
| US10301257B2 (en) | 2011-09-16 | 2019-05-28 | Bayer Intellectual Property Gmbh | Use of acylsulfonamides for improving plant yield |
| IN2014CN01860A (en) | 2011-09-16 | 2015-05-29 | Bayer Ip Gmbh | |
| BR112014006940A2 (en) | 2011-09-23 | 2017-04-04 | Bayer Ip Gmbh | use of 4-substituted 1-phenylpyrazol-3-carboxylic acid derivatives as abiotic stress agents in plants |
| US20150082495A1 (en) | 2011-10-04 | 2015-03-19 | Bayer Intellectual Property Gmbh | RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE |
| WO2013050324A1 (en) | 2011-10-06 | 2013-04-11 | Bayer Intellectual Property Gmbh | Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress |
| MX2014005976A (en) | 2011-11-21 | 2014-08-27 | Bayer Ip Gmbh | Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives. |
| CA2857438A1 (en) | 2011-11-30 | 2013-06-06 | Bayer Intellectual Property Gmbh | Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives |
| CA2859467C (en) | 2011-12-19 | 2019-10-01 | Bayer Cropscience Ag | Use of anthranilic acid diamide derivatives for pest control in transgenic crops |
| MX343818B (en) | 2011-12-29 | 2016-11-24 | Bayer Ip Gmbh | Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-sub stituted-1,2,4-oxadiazol-5(2h)-one derivatives. |
| MX343871B (en) | 2011-12-29 | 2016-11-25 | Bayer Ip Gmbh | Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substit uted-1,2,4-oxadiazol-5(2h)-one derivatives. |
| PT2816897T (en) | 2012-02-22 | 2018-04-02 | Bayer Cropscience Ag | Use of fluopyram for controlling wood diseases in grape |
| PE20190342A1 (en) | 2012-02-27 | 2019-03-07 | Bayer Ip Gmbh | ACTIVE COMPOUND COMBINATIONS |
| WO2013139949A1 (en) | 2012-03-23 | 2013-09-26 | Bayer Intellectual Property Gmbh | Compositions comprising a strigolactame compound for enhanced plant growth and yield |
| WO2013153143A1 (en) | 2012-04-12 | 2013-10-17 | Bayer Cropscience Ag | N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides |
| CN104428294B (en) | 2012-04-20 | 2017-07-14 | 拜尔农科股份公司 | N cycloalkyl N [(heterocyclyl phenyl) methylene] (thio) carboxamide derivative |
| EP2838363A1 (en) | 2012-04-20 | 2015-02-25 | Bayer Cropscience AG | N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives |
| US11518997B2 (en) | 2012-04-23 | 2022-12-06 | BASF Agricultural Solutions Seed US LLC | Targeted genome engineering in plants |
| EP2662361A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazol indanyl carboxamides |
| EP2662364A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole tetrahydronaphthyl carboxamides |
| EP2662363A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole biphenylcarboxamides |
| US9375005B2 (en) | 2012-05-09 | 2016-06-28 | Bayer Cropscience Ag | 5-halogenopyrazole indanyl carboxamides |
| EP2662360A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole indanyl carboxamides |
| EP2662362A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole indanyl carboxamides |
| EP2662370A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole benzofuranyl carboxamides |
| EP2847170B1 (en) | 2012-05-09 | 2017-11-08 | Bayer CropScience AG | Pyrazole indanyl carboxamides |
| AR091104A1 (en) | 2012-05-22 | 2015-01-14 | Bayer Cropscience Ag | COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A LIPO-CHYTOOLIGOSACARIDE DERIVATIVE AND A NEMATICIDE, INSECTICIDE OR FUNGICIDE COMPOUND |
| WO2014009322A1 (en) | 2012-07-11 | 2014-01-16 | Bayer Cropscience Ag | Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress |
| AU2013311826A1 (en) | 2012-09-05 | 2015-03-26 | Bayer Cropscience Ag | Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress |
| CA2888556C (en) | 2012-10-19 | 2020-07-07 | Bayer Cropscience Ag | Method of plant growth promotion using carboxamide derivatives |
| EP2908639A1 (en) | 2012-10-19 | 2015-08-26 | Bayer Cropscience AG | Active compound combinations comprising carboxamide derivatives |
| CN104735985B (en) | 2012-10-19 | 2018-10-16 | 拜尔农科股份公司 | Enhance the method for the tolerance in plant to abiotic stress using carboxylic acid amides or thiocarboxamide derivative |
| PT2908641T (en) | 2012-10-19 | 2018-04-16 | Bayer Cropscience Ag | Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives |
| WO2014079957A1 (en) | 2012-11-23 | 2014-05-30 | Bayer Cropscience Ag | Selective inhibition of ethylene signal transduction |
| EP2735231A1 (en) | 2012-11-23 | 2014-05-28 | Bayer CropScience AG | Active compound combinations |
| CA3105365A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Binary fungicidal mixtures |
| US9775351B2 (en) | 2012-11-30 | 2017-10-03 | Bayer Cropscience Ag | Ternary fungicidal and pesticidal mixtures |
| CA2892701A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Binary pesticidal and fungicidal mixtures |
| MX2015006328A (en) | 2012-11-30 | 2015-09-07 | Bayer Cropscience Ag | FUNGICIDE MIX OR BINARY PESTICIDE. |
| MX382421B (en) | 2012-11-30 | 2025-03-13 | Bayer Cropscience Ag | TERNARY FUNGICIDAL MIXTURES. |
| CN105072903A (en) | 2012-12-05 | 2015-11-18 | 拜耳作物科学股份公司 | Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress |
| EP2740356A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives |
| EP2740720A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants |
| WO2014090765A1 (en) | 2012-12-12 | 2014-06-19 | Bayer Cropscience Ag | Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops |
| AR093996A1 (en) | 2012-12-18 | 2015-07-01 | Bayer Cropscience Ag | BACTERICIDAL COMBINATIONS AND BINARY FUNGICIDES |
| CN104995174A (en) | 2012-12-19 | 2015-10-21 | 拜耳作物科学股份公司 | Difluoromethyl-nicotinic-tetrahydronaphtyl carboxamides |
| WO2014135608A1 (en) | 2013-03-07 | 2014-09-12 | Bayer Cropscience Ag | Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives |
| WO2014161821A1 (en) | 2013-04-02 | 2014-10-09 | Bayer Cropscience Nv | Targeted genome engineering in eukaryotes |
| WO2014167009A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Ag | Novel triazole derivatives |
| EP2984080B1 (en) | 2013-04-12 | 2017-08-30 | Bayer CropScience Aktiengesellschaft | Novel triazolinthione derivatives |
| MX358633B (en) | 2013-04-19 | 2018-08-28 | Bayer Cropscience Ag | Method for improved utilization of the production potential of transgenic plants involving the application of a phthaldiamide derivative. |
| US9554573B2 (en) | 2013-04-19 | 2017-01-31 | Bayer Cropscience Aktiengesellschaft | Binary insecticidal or pesticidal mixture |
| WO2014177514A1 (en) | 2013-04-30 | 2014-11-06 | Bayer Cropscience Ag | Nematicidal n-substituted phenethylcarboxamides |
| TW201507722A (en) | 2013-04-30 | 2015-03-01 | Bayer Cropscience Ag | N-(2-halogen-2-phenethyl)carboxamides as nematicides and endoparasiticides |
| BR112015031235A2 (en) | 2013-06-26 | 2017-07-25 | Bayer Cropscience Ag | n-cycloalkyl-n - [(bicyclyl-phenyl) methylene] - (thio) carboxamide derivatives |
| MX2016000141A (en) | 2013-07-09 | 2016-03-01 | Bayer Cropscience Ag | Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress. |
| US10071967B2 (en) | 2013-12-05 | 2018-09-11 | Bayer Cropscience Aktiengesellschaft | N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives |
| JP6507165B2 (en) | 2013-12-05 | 2019-04-24 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | N-Cycloalkyl-N-{[2- (1-substituted cycloalkyl) phenyl] methylene}-(thio) carboxamide derivative |
| AR101214A1 (en) | 2014-07-22 | 2016-11-30 | Bayer Cropscience Ag | CIANO-CICLOALQUILPENTA-2,4-DIENOS, CIANO-CICLOALQUILPENT-2-EN-4-INAS, CIANO-HETEROCICLILPENTA-2,4-DIENOS AND CYANO-HETEROCICLILPENT-2-EN-4-INAS REPLACED AS ACTIVE PRINCIPLES PLANTS ABIOTIC |
| AR103024A1 (en) | 2014-12-18 | 2017-04-12 | Bayer Cropscience Ag | SELECTED PYRIDONCARBOXAMIDS OR ITS SALTS AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANTS STRESS |
| WO2016166077A1 (en) | 2015-04-13 | 2016-10-20 | Bayer Cropscience Aktiengesellschaft | N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives |
| WO2016205749A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| CN109688816A (en) | 2016-07-29 | 2019-04-26 | 拜耳作物科学股份公司 | Active compound combinations and methods for protecting plant propagation material |
| EP3515907A1 (en) | 2016-09-22 | 2019-07-31 | Bayer CropScience Aktiengesellschaft | Novel triazole derivatives |
| WO2018054829A1 (en) | 2016-09-22 | 2018-03-29 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives and their use as fungicides |
| US20190225974A1 (en) | 2016-09-23 | 2019-07-25 | BASF Agricultural Solutions Seed US LLC | Targeted genome optimization in plants |
| WO2018064208A1 (en) | 2016-09-28 | 2018-04-05 | The Broad Institute, Inc. | Systematic screening and mapping of regulatory elements in non-coding genomic regions, methods, compositions, and applications thereof |
| BR112019008455A2 (en) | 2016-10-26 | 2019-07-09 | Bayer Cropscience Ag | use of pyraziflumide for the control of sclerotinia spp. in seed treatment applications |
| WO2018104392A1 (en) | 2016-12-08 | 2018-06-14 | Bayer Cropscience Aktiengesellschaft | Use of insecticides for controlling wireworms |
| EP3332645A1 (en) | 2016-12-12 | 2018-06-13 | Bayer Cropscience AG | Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress |
| WO2018108627A1 (en) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants |
| US11591601B2 (en) | 2017-05-05 | 2023-02-28 | The Broad Institute, Inc. | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes |
| WO2018213726A1 (en) | 2017-05-18 | 2018-11-22 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
| WO2019025153A1 (en) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | USE OF SUBSTITUTED N-SULFONYL-N'-ARYLDIAMINOALKANES AND N-SULFONYL-N'-HETEROARYL DIAMINOALKANES OR THEIR SALTS TO INCREASE STRESSTOLERANCE IN PLANTS |
| KR20200066616A (en) | 2017-09-21 | 2020-06-10 | 더 브로드 인스티튜트, 인코퍼레이티드 | Systems, methods and compositions for targeted nucleic acid editing |
| US20230193242A1 (en) | 2017-12-22 | 2023-06-22 | The Broad Institute, Inc. | Cas12b systems, methods, and compositions for targeted dna base editing |
| US10968257B2 (en) | 2018-04-03 | 2021-04-06 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
| EP3802521A1 (en) | 2018-06-04 | 2021-04-14 | Bayer Aktiengesellschaft | Herbicidally active bicyclic benzoylpyrazoles |
| CN113544266A (en) | 2018-12-17 | 2021-10-22 | 博德研究所 | CRISPR-associated transposase system and method of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995004826A1 (en) * | 1993-08-09 | 1995-02-16 | Institut Für Genbiologische Forschung Berlin Gmbh | Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants |
| US5750876A (en) * | 1994-07-28 | 1998-05-12 | Monsanto Company | Isoamylase gene, compositions containing it, and methods of using isoamylases |
| DE4447387A1 (en) * | 1994-12-22 | 1996-06-27 | Inst Genbiologische Forschung | Debranching enzymes from plants and DNA sequences encoding these enzymes |
| DE19618125A1 (en) * | 1996-05-06 | 1997-11-13 | Planttec Biotechnologie Gmbh | Nucleic acid molecules that encode new potato debranching enzymes |
| GB9716185D0 (en) * | 1997-07-31 | 1997-10-08 | Innes John Centre | Starch debranching enzymes |
-
1997
- 1997-09-06 GB GBGB9718863.5A patent/GB9718863D0/en not_active Ceased
-
1998
- 1998-09-04 EP EP98941593A patent/EP1009751A2/en not_active Withdrawn
- 1998-09-04 WO PCT/GB1998/002665 patent/WO1999012950A2/en not_active Ceased
- 1998-09-04 CA CA002302639A patent/CA2302639A1/en not_active Abandoned
- 1998-09-04 AU AU89911/98A patent/AU8991198A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9912950A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9718863D0 (en) | 1997-11-12 |
| WO1999012950A9 (en) | 1999-06-10 |
| AU8991198A (en) | 1999-03-29 |
| WO1999012950A2 (en) | 1999-03-18 |
| WO1999012950A3 (en) | 1999-05-06 |
| CA2302639A1 (en) | 1999-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1009751A2 (en) | Improvements in or relating to stability of plant starches | |
| US6956148B1 (en) | Nucleic acids from cassava encoding starch branching enzyme II (SBEII) and their use | |
| Woolley et al. | Purification and properties of an endo-β-1, 4-glucanase from strawberry and down-regulation of the corresponding gene, cel1 | |
| AU724942B2 (en) | Transgenic potatoes having reduced levels of alpha glucan L- or H-type tuber phosphorylase activity with reduced cold-sweetening | |
| US7153674B2 (en) | Nucleic acid molecules encoding enzymes having fructosyl polymerase activity | |
| US5824798A (en) | Genetically engineered modification of potato to obtain amylopectin-type starch | |
| US6570066B1 (en) | Nucleotide sequences encoding enzymes that alter the carbohydrate concentration and composition in plants | |
| EP0719338B1 (en) | Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants | |
| US6916976B1 (en) | Regulation of gene expression in plants | |
| US5750876A (en) | Isoamylase gene, compositions containing it, and methods of using isoamylases | |
| JP2002518015A (en) | Improvement of or related to plants and plant products | |
| EP0563201A1 (en) | Genetically engineered modification of potato to form amylose-type starch | |
| CA2136828A1 (en) | Dna sequences and plasmids for the preparation of plants with changed sucrose concentration | |
| US5767364A (en) | Endo-1,4-beta-D-glucanase | |
| HUT73468A (en) | Method of improving the quality of stored potatoes | |
| US5856467A (en) | Genetically engineered modification of potato to form amylose-type starch | |
| US5569829A (en) | Transformed tomato plants | |
| CA2529455A1 (en) | Plant limit dextrinase inhibitor | |
| AU727294B2 (en) | Regulation of gene expression in plants | |
| KR20050018626A (en) | COFFEE PLANT WITH REDUCED α-D-GALACTOSIDASE ACTIVITY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20000221 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE DE DK ES FI FR GB GR IT NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20050324 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20060912 |